Document:

EX-10.1

 Exhibit 10.1 

$575,000,000 
 ELASTIC N.V. 

4.125% Senior Notes due 2029 

Purchase Agreement 

June 30, 2021 
 J.P. Morgan Securities LLC

 As Representative of the 

several Initial Purchasers listed 

in Schedule 1 hereto 
 c/o J.P. Morgan Securities
LLC 
 383 Madison Avenue 
 New York, New York 10179 

Ladies and Gentlemen: 
 Elastic N.V., a public
company with limited liability organized under the laws of the Netherlands (the “Company”), proposes to issue and sell to the several initial purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for
whom you are acting as representative (the “Representative”), $575,000,000 principal amount of its 4.125% Senior Notes due 2029 (the “Securities”). The Securities will be issued pursuant to an Indenture to be dated
on or about July 6, 2021 (the “Indenture”), among the Company, the guarantors party thereto (the “Guarantors”) from time to time and U.S. Bank National Association, as trustee (the “Trustee”).
At the Closing Date (as defined below), the Securities will not be guaranteed by any subsidiary of the Company, or any other entity. 
 The Company hereby
confirms its agreement with the several Initial Purchasers concerning the purchase and resale of the Securities, as follows: 

1.    Offering Memorandum and Transaction Information. 

The Securities will be sold to the Initial Purchasers without being registered under the Securities Act of 1933, as amended (the
“Securities Act”), in reliance upon an exemption therefrom. The Company has prepared a preliminary offering memorandum dated June 28, 2021 (the “Preliminary Offering Memorandum”) and will prepare an offering
memorandum dated the date hereof (the “Offering Memorandum”) setting forth information concerning the Company and the Securities. Copies of the Preliminary Offering Memorandum have been, and copies of the Offering Memorandum will
be, delivered by the Company to the Initial Purchasers pursuant to the terms of this purchase agreement (the “Agreement”). The Company hereby confirms that it has authorized the use of the Preliminary Offering Memorandum, the other
Time of Sale Information (as defined below) and the Offering Memorandum in connection with the offering and initial resale of the Securities by the Initial Purchasers in the manner 

  
 1 

 
contemplated by this Agreement. References herein to the Preliminary Offering Memorandum, the Time of Sale Information and the Offering Memorandum shall be deemed to refer to and include any
document incorporated by reference therein and any reference to “amend,” “amendment” or “supplement” with respect to the Preliminary Offering Memorandum or the Offering Memorandum shall be deemed to refer to and include
any documents filed after such date and incorporated by reference therein. Capitalized terms used but not defined herein shall have the meanings given to such terms in the Preliminary Offering Memorandum. 

At or prior to the time when sales of the Securities were first made (the “Time of Sale”), the Company had prepared the
following information (collectively, the “Time of Sale Information”): the Preliminary Offering Memorandum, as supplemented and amended by the written communications listed on Annex A hereto. 

2.    Purchase and Resale of the Securities. 

(a)    The Company agrees to issue and sell the Securities to the several Initial Purchasers as provided in this
Agreement, and each Initial Purchaser, on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, agrees, severally and not jointly, to purchase from the Company the respective
principal amount of Securities set forth opposite such Initial Purchaser’s name in Schedule 1 hereto at a price equal to 98.875% of the principal amount thereof plus accrued interest, if any, from July 6, 2021 to the Closing Date. The
Company will not be obligated to deliver any of the Securities except upon payment for all the Securities to be purchased as provided herein. 

(b)    The Company understands that the Initial Purchasers intend to offer the Securities for resale on the terms set
forth in the Time of Sale Information. Each Initial Purchaser, severally and not jointly, represents, warrants and agrees that: 

(i)    it is a qualified institutional buyer within the meaning of Rule 144A under the Securities Act (a
“QIB”) and an accredited investor within the meaning of Rule 501(a) of Regulation D under the Securities Act (“Regulation D”); 

(ii)    it has not solicited offers for, or offered or sold, and will not solicit offers for, or offer or
sell, the Securities by means of any form of general solicitation or general advertising within the meaning of Rule 502(c) of Regulation D or in any manner involving a public offering within the meaning of Section 4(a)(2) of the Securities Act;
and 
 (iii)    it has not solicited offers for, or offered or sold, and will not solicit offers for, or
offer or sell, the Securities as part of their initial offering except: 
 (A)    to persons whom it
reasonably believes to be QIBs in transactions pursuant to Rule 144A under the Securities Act (“Rule 144A”) and in connection with each such sale, it has taken or will take reasonable steps to ensure that the purchaser of the
Securities is aware that such sale is being made in reliance on Rule 144A; or 

  
 2 

 (B)    in accordance with the restrictions set forth in
Annex C hereto. 
 (c)    Each Initial Purchaser acknowledges and agrees that the Company and, for purposes of the
“no registration” opinions to be delivered to the Initial Purchasers pursuant to Sections 6(f) and 6(h), counsel for the Company and counsel for the Initial Purchasers, respectively, may rely upon the accuracy of the representations and
warranties of the Initial Purchasers, and compliance by the Initial Purchasers with their agreements, contained in paragraph (b) above (including Annex C hereto), and each Initial Purchaser hereby consents to such reliance. 

(d)    The Company acknowledges and agrees that the Initial Purchasers may offer and sell Securities to or through any
affiliate of an Initial Purchaser and that any such affiliate may offer and sell Securities purchased by it to or through any Initial Purchaser, in each case in accordance with the restrictions set forth in Annex C hereto. 

(e)    Payment for and delivery of the Securities will be made at the offices of Davis Polk & Wardwell LLP at
10:00 A.M., New York City time, on July 6, 2021, or at such other time or place on the same or such other date, not later than the fifth business day thereafter, as the Representative and the Company may agree upon in writing. The time and date
of such payment and delivery is referred to herein as the “Closing Date.” 
 (f)    Payment for the
Securities shall be made by wire transfer in immediately available funds to the account(s) specified by the Company to the Representative against delivery to the nominee of The Depository Trust Company (“DTC”), for the account of
the Initial Purchasers, of one or more global notes representing the Securities (collectively, the “Global Note”), with any transfer taxes payable in connection with the sale of the Securities duly paid by the Company. The Global
Note will be made available for inspection by the Representative not later than the business day prior to the Closing Date. 

(g)    The Company acknowledges and agrees that each Initial Purchaser is acting solely in the capacity of an arm’s
length contractual counterparty to the Company with respect to the offering of Securities contemplated hereby (including in connection with determining the terms of the offering) and not as a financial advisor or a fiduciary to, or an agent of, the
Company or any other person. Additionally, neither the Representative nor any other Initial Purchaser is advising the Company or any other person as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Company
shall consult with its own advisors concerning such matters and shall be responsible for making its own independent investigation and appraisal of the transactions contemplated hereby, and the Initial Purchasers shall have no responsibility or
liability to the Company with respect thereto. Any review by the Representative or any Initial Purchaser of the Company and the transactions contemplated hereby or other matters relating to such transactions will be performed solely for the benefit
of the Representative or such Initial Purchaser, as the case may be, and shall not be on behalf of the Company or any other person. 

  
 3 

 3.    Representations and Warranties of the Company. The Company
represents and warrants to each Initial Purchaser that: 
 (a)    Preliminary Offering Memorandum, Time of Sale
Information and Offering Memorandum. The Preliminary Offering Memorandum, as of its date, did not, the Time of Sale Information, at the Time of Sale, did not, and at the Closing Date, will not, and the Offering Memorandum, in the form first used
by the Initial Purchasers to confirm sales of the Securities and as of the Closing Date, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of
the circumstances under which they were made, not misleading; provided that the Company makes no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to any
Initial Purchaser furnished to the Company in writing by such Initial Purchaser through the Representative expressly for use in the Preliminary Offering Memorandum, the Time of Sale Information or the Offering Memorandum. 

(b)    Additional Written Communications. The Company (including its agents and representatives, other than the
Initial Purchasers in their capacity as such) have not prepared, made, used, authorized, approved or referred to and will not prepare, make, use, authorize, approve or refer to any written communication that constitutes an offer to sell or
solicitation of an offer to buy the Securities (each such communication by the Company or its agents and representatives (other than a communication referred to in clauses (i) and (ii) below) an “Issuer Written Communication”)
other than (i) the Preliminary Offering Memorandum, (ii) the Offering Memorandum, (iii) the documents listed on Annex A hereto, including a term sheet substantially in the form of Annex B hereto, which constitute part of the Time of
Sale Information, and (iv) any electronic road show or other written communications, in each case used in accordance with Section 4(c) hereof. Each such Issuer Written Communication, when taken together with the Time of Sale Information at
the Time of Sale, did not, and at the Closing Date will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were
made, not misleading; provided that the Company makes no representation or warranty with respect to any statements or omissions made in each such Issuer Written Communication in reliance upon and in conformity with information relating to any
Initial Purchaser furnished to the Company in writing by such Initial Purchaser through the Representative expressly for use in any Issuer Written Communication. 

(c)    Incorporated Documents. The documents incorporated by reference in each of the Time of Sale Information and
the Offering Memorandum, when they were filed with the Commission, conformed or will conform, as the case may be, in all material respects to the requirements of the Exchange Act, and the rules and regulations of the Commission thereunder, and did
not and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not
misleading. 

  
 4 

 (d)    Financial Statements. The financial statements and the
related notes thereto included or incorporated by reference in each of the Time of Sale Information and the Offering Memorandum present fairly the financial position of the Company and its subsidiaries at the dates indicated and the statement of
operations, stockholders’ equity and cash flows of the Company and its subsidiaries for the periods specified; said financial statements have been prepared in conformity with U.S. generally accepted accounting principles
(“GAAP”) applied on a consistent basis throughout the periods involved. The supporting schedules, if any, present fairly in accordance with GAAP the information required to be stated therein. The selected financial data and the
summary financial information included in the Time of Sale Information and the Offering Memorandum present fairly the information shown therein and have been compiled on a basis consistent with that of the audited financial statements included
therein. Except as included therein, no historical or pro forma financial statements or supporting schedules are required to be included in the Time of Sale Information and the Offering Memorandum (assuming, for this purpose, that the offer and sale
of the Securities were registered under the Securities Act). All disclosures contained in the Time of Sale Information and the Offering Memorandum regarding “non-GAAP financial measures” (as such
term is defined by the rules and regulations of the Commission) comply with Regulation G of the Exchange Act and Item 10 of Regulation S-K of the Securities Act, to the extent applicable. The interactive data
in eXtensible Business Reporting Language included or incorporated by reference in each of the Time of Sale Information and the Offering Memorandum fairly presents the information called for in all material respects and is prepared in accordance
with the Commission’s rules and guidelines applicable thereto. 
 (e)    No Material Adverse Change. Neither
the Company nor any of its subsidiaries has, since the date of the most recent financial statements of the Company included or incorporated by reference in each of the Time of Sale Information and the Offering Memorandum (i) sustained any
material loss or interference with its business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree, (ii) entered into any transaction or
agreement that is material to the Company and its subsidiaries taken as a whole or incurred any liability or obligation, direct or contingent, that is material to the Company and its subsidiaries taken as a whole, or (iii) declared or paid any
dividends on its share capital; and, since the respective dates as of which information is given in the Time of Sale Information and the Offering Memorandum there has not been (x) any change in the share capital (other than as a result of
(i) the exercise, if any, of stock options or the award, if any, of stock options or restricted stock or the vesting or settlement, if any, of restricted stock units or other equity incentive awards in the ordinary course of business pursuant
to the Company’s equity plans that are described in the Time of Sale Information and the Offering Memorandum or (ii) the issuance, if any, of stock upon conversion of Company securities as described in the Time of Sale Information or
(iii) the repurchase upon termination of employment or services pursuant to agreements providing for the right of such repurchase of shares granted under the Company’s equity-based incentive plans that are described in the Time of Sale
Information) or long-term debt of the Company or any of its subsidiaries or (y) any Material Adverse Effect (as defined below); as used in this Agreement, “Material  

  
 5 

 
Adverse Effect” shall mean any material adverse change or effect, or any development involving a prospective material adverse change or effect, in or affecting (i) the business,
properties, general affairs, management, financial position, stockholders’ equity or results of operations of the Company and its subsidiaries, taken as a whole, except as set forth or contemplated in the Time of Sale Information and the
Offering Memorandum, or (ii) the ability of the Company to perform its obligations under this Agreement, including the issuance and sale of the Securities, or to consummate the transactions contemplated in the Time of Sale Information and the
Offering Memorandum. 
 (f)    Organization and Good Standing. Each of the Company and each of its subsidiaries
has been (A) duly organized and is validly existing and in good standing (where such concept or functional equivalent exists) under the laws of its jurisdiction of organization, with power and authority (corporate and other) to own its
properties and conduct its business as described in the Time of Sale Information, and (B) duly qualified as a foreign entity for the transaction of business and is in good standing (where such concept or functional equivalent exists) under the
laws of each other jurisdiction in which it owns or leases properties or conducts any business so as to require such qualification, except, in the case of this clause (B), where the failure to be so qualified or in good standing would not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company does not own or control, directly or indirectly, any corporation, association or other entity other than the subsidiaries listed in Schedule 2 to
this Agreement. 
 (g)    Capitalization. The Company has an authorized share capital as set forth in the Time of
Sale Information and all of the issued shares in the share capital of the Company have been duly and validly authorized and issued and are fully paid and non-assessable; and all of the issued shares in the
share capital of each subsidiary of the Company have been duly and validly authorized and issued, are fully paid and non-assessable and (except, in the case of any
non-U.S. subsidiary, for directors’ qualifying shares) are owned directly or indirectly by the Company, free and clear of all liens, encumbrances, equities or claims, except for such liens or encumbrances
described in the Time of Sale Information and the Offering Memorandum or save for any share transfer restrictions (blokkeringsregeling) pursuant to Section 2:195 of the Dutch Civil Code. 

(h)    Due Authorization. The Company has full right, power and authority to execute and deliver this Agreement,
the Securities and the Indenture (collectively, the “Transaction Documents”). 
 (i)    The
Indenture. The Indenture has been duly authorized by the Company and on the Closing Date will have been duly executed and delivered by the Company and, when duly executed and delivered in accordance with its terms by each of the parties thereto,
will constitute a valid and legally binding agreement of the Company enforceable against the Company in accordance with its terms, subject to bankruptcy, insolvency, financial assistance, fraudulent conveyance, fraudulent transfer, re-organization, moratorium or similar laws affecting creditors’ rights generally or by 

  
 6 

 
equitable principles relating to enforceability, including principles of materiality, reasonableness, good faith and fair dealing (regardless of whether enforcement is sought in a proceeding at
law or equity (collectively, the “Enforceability Exceptions”)). 
 (j)    The Securities. The
Securities have been duly authorized by the Company and, when duly executed, authenticated, issued and delivered as provided in the Indenture and paid for as provided herein, and will constitute valid and legally binding obligations of the Company
enforceable against the Company in accordance with their terms, subject to the Enforceability Exceptions, and will be entitled to the benefits of the Indenture. 

(k)    Purchase Agreement. This Agreement has been duly authorized, executed and delivered by the Company. 

(l)    Descriptions of the Transaction Documents. Each Transaction Document conforms in all material respects to
the description thereof contained in each of the Time of Sale Information and the Offering Memorandum. 
 (m)    No
Violation or Default. Neither the Company nor any of its subsidiaries is (A) in violation of its articles of association, certificate of incorporation or by-laws (or other applicable organizational
document), (B) in violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority, or (C) in default in the performance or observance of any obligation, agreement,
covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement, lease or other agreement or instrument to which it is a party or by which it or any of its properties may be bound, except, in the case of the foregoing
clauses (B) and (C), for such defaults as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. 

(n)    No Conflicts; No Consents Required. The execution, delivery and performance by the Company of each of the
Transaction Documents, the issuance and sale of the Securities and compliance by the Company with the terms thereof and the consummation of the transactions contemplated by the Transaction Documents will not result in a breach or violation of any of
the terms or provisions of, or constitute a default under, (A) any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of
its subsidiaries is bound or to which any of the property or assets of the Company or any of its subsidiaries is subject, except, in the case of this clause (A) for such defaults, breaches, or violations that would not, individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect, (B) the articles of association, certificate of incorporation or by-laws (or other applicable organizational document) of the Company
or any of its subsidiaries, or (C) in violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority, except, in the case of this clause (C) for such breaches
or violations that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; no consent, approval, authorization, order, registration or qualification of or with any such court or governmental agency or
body is 

  
 7 

 
required for the execution, delivery and performance by the Company of each of the Transaction Documents, the issue and sale of the Securities or the consummation by the Company of the
transactions contemplated by the Transaction Documents except for such consents, approvals, authorizations, orders, registrations or qualifications as may be required under applicable state securities or Blue Sky laws in connection with the purchase
and initial resale of the Securities by the Initial Purchasers. 
 (o)    Legal Proceedings. Except as described
in each of the Time of Sale Information and the Offering Memorandum, there are no legal or governmental proceedings pending to which the Company or any of its subsidiaries or, to the Company’s knowledge, any officer or director of the Company,
is a party or of which any property or assets of the Company or any of its subsidiaries or, to the Company’s knowledge, any officer or director of the Company, is the subject which would individually or in the aggregate reasonably be expected
to have a Material Adverse Effect; and, to the Company’s knowledge, no such proceedings are threatened or contemplated by governmental or regulatory authorities or others. 

(p)    Independent Accountants. PricewaterhouseCoopers LLP, who have certified certain financial statements of the
Company and its subsidiaries is an independent registered public accounting firm as required by the Securities Act and the rules and regulations of the Commission and the Public Company Accounting Oversight Board (United States) thereunder. 

(q)    Title to Real and Personal Property. The Company and its subsidiaries have good and marketable title in fee
simple to all real property and good and marketable title to all personal property (other than with respect to Intellectual Property (as defined below), which is addressed exclusively in Section 3(r)) owned by them, in each case free and clear
of all liens, encumbrances and defects except such as are described in the Time of Sale Information and the Offering Memorandum or such as do not materially affect the value of such property and do not materially interfere with the use made and
proposed to be made of such property by the Company and its subsidiaries; and any real property and buildings held under lease by the Company and its subsidiaries are held by them under valid, subsisting and enforceable leases (subject to the
effects of (A) bankruptcy, insolvency, fraudulent conveyance, fraudulent transfer, reorganization, moratorium or other similar laws relating to or affecting rights or remedies of creditors generally; (B) the application of general
principles of equity (including without limitation, concepts of materiality, reasonableness, good faith and fair dealing, regardless of whether enforcement is considered in proceedings at law or in equity); and (C) applicable laws and public
policy with respect to rights to indemnity and contribution) with such exceptions as are not material and do not materially interfere with the use made and proposed to be made of such property and buildings by the Company and its subsidiaries. 

(r)    Intellectual Property. The Company and its subsidiaries own or possess, or can acquire on commercially
reasonable terms, sufficient rights to use all inventions, patents, trademarks, service marks, trade names, domain names, copyrights, licenses, technology, know-how, trade secrets and other intellectual
property and proprietary or 

  
 8 

 
confidential information, systems or procedures (including all goodwill associated with, and all registrations of, and applications by the Company and its subsidiaries for registration of, the
foregoing) (collectively, “Intellectual Property”) necessary for or material to the conduct of their respective businesses as currently conducted by them, except where the failure to own, possess or acquire any of the foregoing
would not, individually or in the aggregate, have a Material Adverse Effect on the Company and its subsidiaries, taken as a whole. The conduct of the respective businesses of the Company and its subsidiaries do not infringe, misappropriate or
otherwise violate any Intellectual Property of others, except where such infringement, misappropriation or other violation would not reasonably be expected to have a Material Adverse Effect on the Company and its subsidiaries, taken as a whole.
Except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect on the Company and its subsidiaries, taken as a whole, there is no pending or, to the Company’s knowledge, threatened action, suit,
proceeding or claim (i) challenging the Company’s or any subsidiary of the Company’s rights in or to, or alleging the violation by the Company or any of its subsidiaries of any of the terms of, any of their Intellectual Property;
(ii) alleging that the Company or any of its subsidiaries has infringed, misappropriated or otherwise violated or conflicted with any Intellectual Property of any third party; or (iii) challenging the validity, scope or enforceability of
any Intellectual Property owned by or exclusively licensed to the Company or any of its subsidiaries. Except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect on the Company and its
subsidiaries, taken as a whole, all Intellectual Property owned by the Company or its subsidiaries is owned solely by the Company or its subsidiaries, is owned free and clear of all liens, encumbrances, defects and other restrictions (except for non-exclusive licenses granted to third parties in the ordinary course of business consistent with past practice), and to the knowledge of the Company, no third party has infringed, misappropriated or otherwise
violated any Intellectual Property owned by or exclusively licensed to the Company or any of its subsidiaries. The Company and its subsidiaries have taken reasonable steps in accordance with customary industry practice to maintain the
confidentiality of all Intellectual Property, the value of which to the Company or any of its subsidiaries is contingent upon maintaining the confidentiality thereof. 

(s)    Open Source Software. The Company and its subsidiaries have used all software and other materials
distributed under a “free,” “open source,” or similar licensing model (including but not limited to the MIT License, Apache License, GNU General Public License, GNU Lesser General Public License and GNU Affero General Public
License) (“Open Source Software”) in compliance with all license terms applicable to such Open Source Software, except where the failure to comply would not have, individually or in the aggregate, a Material Adverse Effect on the
Company and its subsidiaries, taken as a whole; and neither the Company nor any of its subsidiaries has used or distributed any Open Source Software in a manner that requires or has required (i) the Company or any of its subsidiaries to permit
reverse engineering of any products or services of the Company or any of its subsidiaries, or any software code or other technology owned by the Company or any of its subsidiaries or (ii) any products or services of the Company or any of its
subsidiaries, or any software code or other technology owned by the Company or any of its subsidiaries, to be (A) disclosed or 

  
 9 

 
distributed in source code form, (B) licensed for the purpose of making derivative works, or (C) redistributed at no charge, except, as would not, individually or in the aggregate, have
a Material Adverse Effect on the Company and its subsidiaries, taken as a whole. 
 (t)    Company IT
Systems. To the Company’s knowledge, the Company and its subsidiaries own or have a valid right to access and use all computer systems, networks, hardware, software, databases, websites, and equipment used to process, store,
maintain and operate data, information, and functions used by or on behalf of the Company or its subsidiaries in connection with the business of the Company and its subsidiaries (the “Company IT Systems”), except as has not had and
would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect on the Company and its subsidiaries, taken as a whole. To the Company’s knowledge, the Company IT Systems (i) are adequate for, and
operate and perform in all material respects in accordance with their documentation and functional specifications and otherwise as required in connection with the operation of the business of the Company and its subsidiaries as currently conducted,
(ii) have not materially malfunctioned or failed, and (iii) are free of any viruses, “back doors,” “Trojan horses,” “time bombs,” “worms,” “drop dead devices” or other software or hardware
components that are designed to interrupt use of, permit unauthorized access to, or disable, damage or erase, any software material to the business of the Company or any of its subsidiaries, except in the case of each of (i) through (iii) as
has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect on the Company and its subsidiaries, taken as a whole. The Company and its subsidiaries have implemented reasonable backup,
security and disaster recovery technology consistent with applicable regulatory standards, except where in each of the foregoing cases, as such failure has not had and would not, individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect on the Company and its subsidiaries, taken as a whole. To the Company’s knowledge, except as has not had and would not, individually or in the aggregate, reasonably be expected to have, a Material Adverse Effect on the
Company and its subsidiaries, taken as a whole, no person has gained unauthorized access to Company IT Systems in a manner that resulted in a breach of security of confidential information or personal data in the possession of, or stored by or on
behalf of, the Company or its subsidiaries. 
 (u)    Data Privacy. The Company and its
subsidiaries have (i) complied, and are presently in compliance, with their respective privacy policies and other legal obligations regarding the collection, use, transfer, storage, protection, disposal and disclosure by the Company and its
subsidiaries of personally identifiable user information gathered or accessed in the course of their respective operations, and (ii) with respect to all such information, have taken reasonable steps in accordance with industry standard
practices (including, without limitation, implementing and monitoring compliance with adequate reasonable measures with respect to technical and physical security) to protect such information against loss and against unauthorized access, use,
modification, disclosure or other misuse, except in the case of (i) and (ii), to the extent that the failure to do so would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect on the Company and its
subsidiaries, taken as a whole. To the knowledge of the Company, except as would not individually or in the aggregate have a Material Adverse Effect on the Company and its subsidiaries, taken as a whole, there has been no unauthorized access to such
information. 

  
 10 

 (v)    No Undisclosed Relationships. No relationship, direct or
indirect, exists between or among the Company or any of its subsidiaries, on the one hand, and the directors, officers, stockholders, customers, suppliers or other affiliates of the Company or any of its subsidiaries, on the other, that would be
required by the Securities Act to be described in a registration statement on Form S-1 to be filed with the Commission and that is not so described in each of the Time of Sale Information and the Offering
Memorandum. 
 (w)    Investment Company Act. The Company is not, and immediately after giving effect to the
offering and sale of the Securities and the application of the proceeds thereof as described in each of the Time of Sale Information and the Offering Memorandum, will not be, required to register as an “investment company” or an entity
“controlled” by an “investment company” within the meaning of the Investment Company Act of 1940, as amended, and the rules and the regulations of the Commission thereunder. 

(x)    Taxes. The Company and its subsidiaries have filed all tax returns that are required to have been filed by
them pursuant to Netherlands, U.S., non-U.S., state, local and other law except insofar as the failure to file such returns would not reasonably be expected to result in a Material Adverse Effect, and have
paid all taxes due pursuant to such returns or pursuant to any assessment received by the Company and its subsidiaries, except for such taxes, if any, as are being contested in good faith and as to which adequate reserves have been established by
the Company or insofar as the failure to pay such taxes would not reasonably be expected to result in a Material Adverse Effect. The charges, accruals and reserves on the books of the Company in respect of any income and corporation tax liability
for any years not finally determined are, in conformity with GAAP, adequate to meet any assessments or re-assessments for additional income tax for any years not finally determined, except to the extent of any
inadequacy that would not reasonably be expected to result in a Material Adverse Effect;. 
 (y)    Transfer
Taxes. Except as disclosed in the Time of Sale Information and the Offering Memorandum, there are no transfer taxes, stamp duty or other similar fees or charges under Netherlands or U.S. federal law or the laws of any U.S. state,
or any political subdivision thereof, required to be paid in connection with the execution and delivery of the Transaction Documents or the sale, issuance and delivery of the Securities by the Company through the facilities of DTC. 

(z)    Licenses and Permits. The Company and its subsidiaries possess all licenses, permits, certificates and other
authorizations from, and have made all declarations and filings with, all governmental or regulatory authorities, required or necessary to own or lease, as the case may be, and to operate their respective properties and to carry on their respective
businesses as currently conducted by them or as described in the Time of Sale Information and the Offering Memorandum to be 

  
 11 

 
conducted by them (“Permits”), and such Permits are in full force and effect, and neither the Company nor its subsidiaries has received any written notice of proceedings relating
to the revocation or modification of any such Permit, except where the failure to obtain, possess or be in compliance with such Permits would not, individually or in the aggregate, be reasonably expected to have a Material Adverse Effect. 

(aa)    No Labor Disputes. No material labor dispute with or disturbance by the employees of the Company or any of
its subsidiaries exists or is threatened, and neither the Company nor any of its subsidiaries has received notice of any pending or threatened activities or proceedings by any labor union or similar entity to organize any employees of the Company or
its subsidiaries that, individually or in the aggregate, could reasonably be expected to have a Material Adverse Effect. 

(bb)    Certain Environmental Matters. (A) Neither the Company nor any of its subsidiaries is in material
violation of any applicable statute, law, rule, regulation, ordinance, code, rule of common law or order of or with any governmental agency or body or any court, domestic or foreign, relating to the use, management, disposal or release of hazardous
or toxic substances or wastes or relating to pollution or the protection of the environment or human health or relating to exposure to hazardous or toxic substances or wastes (collectively, “Environmental Laws”) applicable to such
entity, (B) neither the Company nor any of its subsidiaries has received any written claim, written request for information or written notice of liability or investigation arising under, relating to or based upon any Environmental Laws, and
(C) neither the Company nor any of its subsidiaries is aware of any pending or threatened notice, claim, proceeding or investigation which might lead to liability under Environmental Laws, except, in each case, where the failure to comply or
the potential liability or obligation would not, individually or in the aggregate, be reasonably expected to have a Material Adverse Effect. 

(cc)    Disclosure Controls. The Company and its subsidiaries maintain an effective system of “disclosure
controls and procedures” (as defined in Rule 13a-15(e) of the Exchange Act) that is designed to ensure that information required to be disclosed by the Company in reports that it files or submits under
the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated
to the Company’s management as appropriate to allow timely decisions regarding required disclosure. The Company and its subsidiaries have carried out evaluations of the effectiveness of their disclosure controls and procedures as required by
Rule 13a-15 of the Exchange Act. 
 (dd)    Accounting Controls. The
Company maintains a system of internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Exchange Act) that (i) complies in all material respects with the
requirements of the Exchange Act, (ii) has been designed by the Company’s principal executive officer and principal financial officer, or under their supervision, to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for 

  
 12 

 
external purposes in accordance with GAAP and (iii) is designed to provide reasonable assurance that (A) transactions are executed in accordance with management’s general or
specific authorization, (B) transactions are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles and to maintain accountability for assets, (C) access to assets is
permitted only in accordance with management’s general or specific authorization and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to
any differences and (D) interactive data in eXtensible Business Reporting Language included or incorporated by reference in each of the Preliminary Offering Memorandum, the Time of Sale Information and the Offering Memorandum is prepared in
accordance with the Commission’s rules and guidelines applicable thereto. The Company’s internal control over financial reporting is effective and the Company is not aware of any material weaknesses in its internal control over financial
reporting. 
 (ee)    Insurance. The Company and its subsidiaries, taken as a whole, are insured by insurers of
recognized financial responsibility against such losses and risks and in such amounts as are commercially reasonable and customary for the conduct of their collective business; and the Company has no reason to believe that it will not be able to
renew its existing insurance coverage as and when such coverage expires or to obtains similar coverage from similar insurers. 

(ff)    No Unlawful Payments. None of the Company nor any of its subsidiaries, nor any director or officer of the
Company or any of its subsidiaries nor, to the knowledge of the Company, any employee, agent, other affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries, has (A) made, offered, promised or
authorized any unlawful contribution, gift, entertainment or other unlawful expense; (B) made, offered, promised or authorized any direct or indirect unlawful payment; or (C) violated or is in violation of any provision of the Foreign
Corrupt Practices Act of 1977, the Bribery Act 2010 of the United Kingdom or any other applicable anti-bribery or anti-corruption law. The Company and its subsidiaries have conducted their businesses in compliance with applicable anti-corruption
laws and have instituted and maintained and will continue to maintain policies and procedures reasonably designed to promote and achieve compliance with such laws and with the representations and warranties contained herein. Neither the Company nor
its subsidiaries will use, directly or indirectly, the net proceeds of the sale of the Securities in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any person in
violation of any applicable anti-corruption laws. 
 (gg)    Compliance with Anti-Money Laundering Laws. The
operations of the Company and its subsidiaries are and have been conducted at all times in compliance with the requirements of applicable anti-money laundering laws, including, but not limited to, the Bank Secrecy Act of 1970, as amended by the USA
PATRIOT ACT of 2001, and the rules and regulations promulgated thereunder, and the anti-money laundering laws of the various jurisdictions in which the Company and its subsidiaries conduct business (collectively, the “Money Laundering
Laws”) and no action, suit or 

  
 13 

 
proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is pending
or, to the knowledge of the Company, threatened. 
 (hh)    No Conflicts with Sanctions Laws. None of the Company
or any of its subsidiaries nor any director or officer of the Company or any of its subsidiaries, nor, to the knowledge of the Company, any other employee, agent or affiliate of the Company or any of its subsidiaries is currently the subject or the
target of any sanctions administered or enforced by the U.S. government, including, without limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury (“OFAC”), or the U.S. Department of State and
including, without limitation, the designation as a “specially designated national” or “blocked person,” the European Union, Her Majesty’s Treasury, the United Nations Security Council, or other relevant sanctions authority
(collectively, “Sanctions”), or is located, organized or resident in a country or territory that is the subject of Sanctions (including, without limitation, Crimea, Cuba, Iran, North Korea and Syria) and the Company will not
directly or indirectly use the proceeds of the offering of the Securities hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity (A) to fund or facilitate any
activities of or business with any person, or in any country or territory, that, at the time of such funding, is the subject or the target of Sanctions or (B) in any other manner that will result in a violation by any person (including any
person participating in the transaction, whether as initial purchaser, advisor, investor or otherwise) of Sanctions. For the past five years, the Company and its subsidiaries have not knowingly engaged in, are not now knowingly engaged in, and will
not engage in, any dealings or transactions with any person, or in any country or territory, that at the time of the dealing or transaction is or was the subject of Sanctions to the extent it would result in a violation of any Sanctions. 

(ii)    Solvency. On and immediately after the Closing Date, the Company (after giving effect to the issuance and
sale of the Securities and the other transactions related thereto as described in each of the Time of Sale Information and the Offering Memorandum) will be Solvent. As used in this paragraph, the term “Solvent” means, with respect
to a particular date and entity, that on such date (i) the fair value (and present fair saleable value) of the assets of such entity is not less than the total amount required to pay the probable liability of such entity on its total existing
debts and liabilities (including contingent liabilities) as they become absolute and matured; (ii) such entity is able to realize upon its assets and pay its debts and other liabilities, contingent obligations and commitments as they mature and
become due in the normal course of business; (iii) assuming consummation of the issuance and sale of the Securities as contemplated by this Agreement, the Time of Sale Information and the Offering Memorandum, such entity does not have, intend
to incur or believe that it will incur debts or liabilities beyond its ability to pay as such debts and liabilities mature; (iv) such entity is not engaged in any business or transaction, and does not propose to engage in any business or
transaction, for which its property would constitute unreasonably small capital; and (v) such entity is not a defendant in any civil action that would result in a judgment that such entity is or would become unable to satisfy. 

  
 14 

 (jj)    No Restrictions on Subsidiaries. No subsidiary of the
Company is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, from paying any dividends to the Company, from making any other distribution on such subsidiary’s capital
stock or similar ownership interest (in each case, subject to applicable law), from repaying to the Company any loans or advances to such subsidiary from the Company or from transferring any of such subsidiary’s properties or assets to the
Company or any other subsidiary of the Company except as described in each of the Time of Sale Information and the Offering Memorandum. 

(kk)    No Broker’s Fees. Except as described in the Time of Sale Information and the Offering
Memorandum, there are no contracts, agreements or understandings between the Company and any person that would give rise to a valid claim against the Company or any Initial Purchaser for a brokerage commission, finder’s fee or other like
payment in connection with this offering. 
 (ll)    Rule 144A Eligibility. On the Closing Date, the Securities
will not be of the same class as securities listed on a national securities exchange registered under Section 6 of the Exchange Act or quoted in an automated inter-dealer quotation system; and each of the Preliminary Offering Memorandum and the
Offering Memorandum, as of its respective date, contains or will contain all the information that, if requested by a prospective purchaser of the Securities, would be required to be provided to such prospective purchaser pursuant to Rule 144A(d)(4)
under the Securities Act. 
 (mm)    No Integration. Neither the Company nor any of its affiliates (as defined in
Rule 501(b) of Regulation D) has, directly or through any agent, sold, offered for sale, solicited offers to buy or otherwise negotiated in respect of, any security (as defined in the Securities Act), that is or will be integrated with the sale of
the Securities in a manner that would require registration of the Securities under the Securities Act. 
 (nn)    No
General Solicitation or Directed Selling Efforts. None of the Company or any of its controlled affiliates or any other person acting on its or their behalf (other than the Initial Purchasers, as to which no representation is made) has
(i) solicited offers for, or offered or sold, the Securities by means of any form of general solicitation or general advertising within the meaning of Rule 502(c) of Regulation D or in any manner involving a public offering within the meaning
of Section 4(a)(2) of the Securities Act or (ii) engaged in any directed selling efforts within the meaning of Regulation S under the Securities Act (“Regulation S”), and all such persons have complied with the offering
restrictions requirement of Regulation S. 
 (oo)    Securities Law Exemptions. Assuming the accuracy of the
representations and warranties of the Initial Purchasers contained in Section 2(b) (including Annex C hereto) and their compliance with their agreements set forth therein, it is not necessary, in connection with the issuance and sale of the
Securities to the Initial Purchasers and the offer, resale and delivery of the Securities by the Initial Purchasers in the manner contemplated by this Agreement, the Time of Sale Information and the Offering Memorandum, to register the Securities
under the Securities Act or to qualify the Indenture under the Trust Indenture Act. 

  
 15 

 (pp)    No Stabilization. Neither the Company nor
any of the Guarantors has taken, directly or indirectly, any action designed to or that could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Securities. 

(qq)    Margin Rules. Neither the issuance, sale and delivery of the Securities nor the application of the proceeds
thereof by the Company as described in each of the Time of Sale Information and the Offering Memorandum will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.

 (rr)    Forward-Looking Statements. No forward-looking statement (within the meaning of Section 27A of
the Securities Act and Section 21E of the Exchange Act) included or incorporated by reference in any of the Time of Sale Information or the Offering Memorandum has been made or reaffirmed without a reasonable basis or has been disclosed other
than in good faith. 
 (ss)    Statistical and Market Data. Any statistical, industry-related and market-related
data included or incorporated by reference in the Time of Sale Information and the Offering Memorandum are based on or derived from sources that the Company believes, after reasonable inquiry, to be reliable and accurate in all material respects.

 (tt)    Sarbanes-Oxley Act. There is and has been no failure on the part of the Company or any of the
Company’s directors or officers, in their capacities as such, to comply in all material respects with any provision of the Sarbanes-Oxley Act of 2002, as amended, and the rules and regulations promulgated in connection therewith (the
“Sarbanes-Oxley Act”), including Section 402 related to loans and Sections 302 and 906 related to certifications. 

(uu)    No Withholding Tax. All payments to be made by the Company on or by virtue of the execution delivery,
performance or enforcement of the Transaction Documents and, except as disclosed in each of the Time of Sale Information and the Offering Memorandum, all interest, principal, premium, if any, additional amounts, if any, and other payments under the
Transaction Documents, under the current laws and regulations of the United States of America or the Netherlands, any political subdivision thereof or any applicable taxing jurisdiction (each, a “Taxing Jurisdiction”), will not be
subject to withholding, duties, levies, deductions, charges or other taxes under the current laws and regulations of the Taxing Jurisdiction and are otherwise payable free and clear of any other withholding, duty, levy, deduction, charge or other
tax in the Taxing Jurisdiction and without the necessity of obtaining any governmental authorization in the Taxing Jurisdiction. 

(vv)    No Immunity. Neither the Company nor any of its subsidiaries or their properties or assets has immunity
under Dutch, U.S. federal or New York state law from any legal action, suit or proceeding, from the giving of any relief in any such legal action, 

  
 16 

 
suit or proceeding, from set-off or counterclaim, from the jurisdiction of any Dutch, U.S. federal or New York state court, from service of process,
attachment upon or prior to judgment, or attachment in aid of execution of judgment, or from execution of a judgment, or other legal process or proceeding for the giving of any relief or for the enforcement of a judgment, in any such court with
respect to their respective obligations, liabilities or any other matter under or arising out of or in connection herewith; and, to the extent that the Company or any of its subsidiaries or any of its properties, assets or revenues may have or may
hereafter become entitled to any such right of immunity in any such court in which proceedings arising out of, or relating to the transactions contemplated by the Transaction Documents, may at any time be commenced, the Company has, pursuant to
Section 16(g) of this Agreement, waived, and it will waive, or will cause its subsidiaries to waive, such right to the extent permitted by law. 

(ww)    Enforcement of Foreign Judgments. A judgment in a civil or commercial matter rendered by a U.S. court would
generally be enforced in the Netherlands if (i) a person has obtained a final judgment without appeal in such a matter rendered by a U.S court which is enforceable in a U.S. court, (ii) such person files its claim with a Dutch court with
jurisdiction, (iii) the Dutch court finds that (A) the jurisdiction of the court has been based on an internationally generally accepted ground, (B) proper legal procedures have been observed, (C) the judgment does not contravene
Dutch public policy, and (D) the judgment is not irreconcilable with a judgment of a Dutch court or an earlier judgment of a foreign court that is capable of being recognized in the Netherlands. 

(xx)    Valid Choice of Law. The choice of laws of the State of New York as the governing law of the Transaction
Documents is a valid choice of law under the laws of the Netherlands and will be honored by the courts of the Netherlands, subject to inevitable judiciary discretion and the restrictions described under the caption “Enforceability of
Judgments” in the Time of Sale Information and the Offering Memorandum. The Company has the power to submit, pursuant to Section 16(d) of this Agreement has submitted, and pursuant to the Indenture will submit, legally, validly,
effectively and irrevocably, to the personal jurisdiction of each New York state and United States federal court sitting in the City of New York and has validly and irrevocably waived any objection to the laying of venue of any suit, action or
proceeding brought in such court. 
 (yy)    Exchange Controls. No exchange control authorization or any other
authorization, approval, consent or license of any governmental or regulatory authority or court in the Netherlands is required for the payment of any amounts payable under the Transaction Documents and all interest, principal, premium, if any,
additional amounts, if any, and other payments on or under the Transaction Documents; all such payments will otherwise, except as disclosed in the Time of Sale Information and the Offering Memorandum, be free and clear of any other tax, duty,
withholding or deduction in the Netherlands or any political subdivision or taxing authority thereof or therein and may be paid in euros that may be converted into another currency and freely transferred out of the Netherlands, without the necessity
of obtaining any governmental authorization in the Netherlands or any political subdivision or taxing authority thereof or therein. 

  
 17 

 (zz)    Indemnification and Contribution. The indemnification and
contribution provisions set forth in Section 7 hereof do not contravene Dutch law or public policy. 

(aaa)    No Requirement to File or Record. This Agreement and the other Transaction Documents are in proper legal
form under the laws of the Netherlands for the enforcement thereof in the Netherlands against the Company, and to ensure the legality, enforcement or admissibility into evidence of this Agreement and any other Transaction Document in the
Netherlands, it is not necessary for this Agreement or any such Transaction Document, as the case may be, to be filed or recorded with any court or other authority in the Netherlands or that any tax or fee be paid in the Netherlands on or in respect
of this Agreement or such Transaction Document, as the case may be, or any other document, other than court costs (including, without limitation, filing fees). This Agreement and the other Transaction Documents are in proper legal form under the
laws of the State of New York for the enforcement thereof in the State of New York against the Company, and it is not necessary in order to ensure the legality, validity, enforcement or admissibility into evidence of this Agreement and any other
Transaction Document in the State of New York that this Agreement or any such Transaction Document, as the case may be, be filed or recorded with any court or other authority in the State of New York or that any tax or fee be paid in the State of
New York on or in respect of this Agreement or such Transaction Document, as the case may be, or any other document, other than court costs, including (without limitation) filing fees. 

(bbb)    Foreign Enforcement. A holder of the Securities and each Initial Purchaser are each entitled
to sue as plaintiff in the court of the jurisdiction of formation and domicile of the Company for the enforcement of their respective rights under the Transaction Documents and the Securities and such access to such courts will not be subject to any
conditions which are not applicable to residents of such jurisdiction or a company incorporated in such jurisdiction except that plaintiffs not residing in the Netherlands may be required to guarantee payment of a possible order for payment of costs
and / or damages at the request of the defendant. 
 4.    Further Agreements of the Company and the Guarantors.
The Company and the Guarantors jointly and severally covenant and agree with each Initial Purchaser that: 

(a)    Delivery of Copies. The Company will deliver, without charge, to the Initial Purchasers as many copies of
the Preliminary Offering Memorandum, any other Time of Sale Information, any Issuer Written Communication and the Offering Memorandum (including all amendments and supplements thereto) as the Representative may reasonably request. 

(b)    Offering Memorandum, Amendments or Supplements. For as long as may be necessary to complete the offer and
sale of the Securities, before finalizing the Offering Memorandum or making or distributing any amendment or supplement to any 

  
 18 

 
of the Time of Sale Information or the Offering Memorandum or filing with the Commission any document that will be incorporated by reference therein, the Company will furnish to the
Representative and counsel for the Initial Purchasers a copy of the proposed Offering Memorandum or such amendment or supplement or document to be incorporated by reference therein for review, and will not distribute any such proposed Offering
Memorandum, amendment or supplement or file any such document with the Commission to which the Representative reasonably objects. 

(c)    Additional Written Communications. Before making, preparing, using, authorizing, approving or referring to
any Issuer Written Communication, the Company and the Guarantors will furnish to the Representative and counsel for the Initial Purchasers a copy of such written communication for review and will not make, prepare, use, authorize, approve or refer
to any such written communication to which the Representative reasonably objects. 
 (d)    Notice to the
Representatives. For as long as may be necessary to complete the offer and sale of the Securities, the Company will advise the Representative promptly, and confirm such advice in writing, (i) of the issuance by any governmental or
regulatory authority of any order preventing or suspending the use of any of the Time of Sale Information, any Issuer Written Communication or the Offering Memorandum or the initiation or threatening of any proceeding for that purpose; (ii) of
the occurrence of any event at any time prior to the completion of the initial offering of the Securities as a result of which any of the Time of Sale Information, any Issuer Written Communication or the Offering Memorandum as then amended or
supplemented would include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances existing when such Time of Sale Information, Issuer Written
Communication or the Offering Memorandum is delivered to a purchaser, not misleading; and (iii) of the receipt by the Company of any notice with respect to any suspension of the qualification of the Securities for offer and sale in any
jurisdiction or the initiation or threatening of any proceeding for such purpose; and the Company will use its reasonable best efforts to prevent the issuance of any such order preventing or suspending the use of any of the Time of Sale Information,
any Issuer Written Communication or the Offering Memorandum or suspending any such qualification of the Securities and, if any such order is issued, will obtain as soon as possible the withdrawal thereof. 

(e)    Time of Sale Information. If at any time prior to the Closing Date (i) any event shall occur or
condition shall exist as a result of which any of the Time of Sale Information as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading or (ii) it is necessary to amend or supplement the Time of Sale Information to comply with law, the Company will immediately notify the Initial Purchasers
thereof and forthwith prepare and, subject to paragraph (b) above, furnish to the Initial Purchasers such amendments or supplements to the Time of Sale Information (or any document to be filed with the Commission and incorporated by reference
therein) as may be 

  
 19 

 
necessary so that the statements in any of the Time of Sale Information as so amended or supplemented (including such documents to be incorporated by reference therein) will not, in the light of
the circumstances under which they were made, be misleading or so that any of the Time of Sale Information will comply with law. 

(f)    Ongoing Compliance. If at any time prior to the completion of the initial offering of the Securities
(i) any event shall occur or condition shall exist as a result of which the Offering Memorandum as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to make
the statements therein, in the light of the circumstances existing when the Offering Memorandum is delivered to a purchaser, not misleading or (ii) it is necessary to amend or supplement the Offering Memorandum to comply with law, the Company
will immediately notify the Initial Purchasers thereof and forthwith prepare and, subject to paragraph (b) above, furnish to the Initial Purchasers such amendments or supplements to the Offering Memorandum (or any document to be filed with the
Commission and incorporated by reference therein) as may be necessary so that the statements in the Offering Memorandum as so amended or supplemented (including such document to be incorporated by reference therein) will not, in the light of the
circumstances existing when the Offering Memorandum is delivered to a purchaser, be misleading or so that the Offering Memorandum will comply with law. 

(g)    Blue Sky Compliance. The Company will qualify the Securities for offer and sale under the securities or Blue
Sky laws of such jurisdictions as the Representative shall reasonably request and will continue such qualifications in effect so long as required for the offering and resale of the Securities; provided that neither the Company nor any of the
Guarantors shall be required to (i) qualify as a foreign corporation or other entity or as a dealer in securities in any such jurisdiction where it would not otherwise be required to so qualify, (ii) file any general consent to service of
process in any such jurisdiction or (iii) subject itself to taxation in any jurisdiction if it is not otherwise so subject or (iv) publish a prospectus pursuant to the Prospectus Regulation. 

(h)    Clear Market. During the period from the date hereof through and including the date that is 60 days after
the date hereof, the Company and each of the Guarantors will not, without the prior written consent of the Representative, offer, sell, contract to sell or otherwise dispose of any debt securities issued or guaranteed by the Company or any of the
Guarantors and having a tenor of more than one year. 
 (i)    Use of Proceeds. The Company will apply the net
proceeds from the sale of the Securities as described in each of the Time of Sale Information and the Offering Memorandum under the heading “Use of proceeds.” 

(j)    Supplying Information. While the Securities remain outstanding and are “restricted securities”
within the meaning of Rule 144(a)(3) under the Securities Act, the Company and each of the Guarantors will, during any period in which the Company is not subject to and in compliance with Section 13 or 15(d) of the Exchange Act, furnish to
holders of the Securities and prospective purchasers of the Securities designated by such holders, upon the request of such holders or such prospective purchasers, the information required to be delivered pursuant to Rule 144A(d)(4) under the
Securities Act. 

  
 20 

 (k)    DTC. The Company will assist the Initial Purchasers in
arranging for the Securities to be eligible for clearance and settlement through DTC. 
 (l)    No Resales by the
Company. The Company will not, and will not permit any of its controlled affiliates (as defined in Rule 144 under the Securities Act) to, resell any of the Securities that have been acquired by any of them, except for Securities purchased
by the Company or any of its controlled affiliates and resold in a transaction registered under the Securities Act. 

(m)    No Integration. Neither the Company nor any of its affiliates (as defined in Rule 501(b) of Regulation D)
will, directly or through any agent, sell, offer for sale, solicit offers to buy or otherwise negotiate in respect of, any security (as defined in the Securities Act), that is or will be integrated with the sale of the Securities in a manner that
would require registration of the Securities under the Securities Act. 
 (n)    No General Solicitation or Directed
Selling Efforts. None of the Company or any of its affiliates or any other person acting on its or their behalf (other than the Initial Purchasers, as to which no covenant is given) will (i) solicit offers for, or offer or sell, the
Securities by means of any form of general solicitation or general advertising within the meaning of Rule 502(c) of Regulation D or in any manner involving a public offering within the meaning of Section 4(a)(2) of the Securities Act or
(ii) engage in any directed selling efforts within the meaning of Regulation S, and all such persons will comply with the offering restrictions requirement of Regulation S. 

(o)    No Stabilization. The Company will not take, directly or indirectly, any action designed to or that could
reasonably be expected to cause or result in any stabilization or manipulation of the price of the Securities. 

(p)    Tax Gross-Up. The Company agrees with each of the Initial Purchasers
to make all payments under the Transaction Documents without withholding or deduction for or on account of any present or future taxes, duties or governmental charges whatsoever imposed by any applicable Taxing Jurisdiction, unless the Company is
compelled by law to deduct or withhold such taxes, duties or charges. In that event, the Company shall pay such additional amounts as may be necessary in order that the net amounts received after such withholding or deduction will equal the amounts
that would have been received if no withholding or deduction has been made, except to the extent that such taxes, duties or charges (a) were imposed due to some connection of an Initial Purchaser with the Taxing Jurisdiction other than the mere
entering into of this Agreement or receipt of payments hereunder or (b) would not have been imposed but for the failure of such Initial Purchaser to comply with any reasonable certification, identification or other reporting requirements
concerning the nationality, residence, identity or connection with the Taxing Jurisdiction of the Initial Purchaser if such compliance is required or imposed by law as a precondition to an exemption from, or reduction in, such taxes, duties or other
charges. The Company agrees to indemnify 

  
 21 

 
and hold harmless the Initial Purchasers against any documentary, stamp, sales, transaction or similar issue tax, including any interest and penalties, on the creation, issue and sale of the
Securities, and on the execution, delivery, performance and enforcement of the Transaction Documents. 

5.    Certain Agreements of the Initial Purchasers. Each Initial Purchaser hereby represents and agrees that it has
not and will not use, authorize use of, refer to, or participate in the planning for use of, any written communication that constitutes an offer to sell or the solicitation of an offer to buy the Securities other than (a) the Preliminary
Offering Memorandum and the Offering Memorandum, (b) any written communication that contains either (i) no “issuer information” (as defined in Rule 433(h)(2) under the Securities Act) or (ii) “issuer information” that
was included (including through incorporation by reference) in the Time of Sale Information or the Offering Memorandum, (c) any written communication listed on Annex A or prepared pursuant to Section 4(c) (including any electronic road
show) above, (d) any written communication prepared by such Initial Purchaser and approved by the Company and the Representative in advance in writing or (e) any written communication relating to or that contains the terms of the
Securities and/or other information that was included (including through incorporation by reference) in the Time of Sale Information or the Offering Memorandum. 

6.    Conditions of Initial Purchasers’ Obligations. The obligation of each Initial Purchaser to
purchase Securities on the Closing Date as provided herein is subject to the performance by the Company of its covenants and other obligations hereunder and to the following additional conditions: 

(a)    Representations and Warranties. The representations and warranties of the Company contained herein shall be
true and correct on the date hereof and on and as of the Closing Date; and the statements of the Company and its respective officers made in any certificates delivered pursuant to this Agreement shall be true and correct on and as of the Closing
Date. 
 (b)    No Downgrade. Subsequent to the earlier of (i) the Time of Sale and (ii) the execution
and delivery of this Agreement, (A) no downgrading shall have occurred in the rating accorded the Securities or any other debt securities or preferred stock issued or guaranteed by the Company or any of its subsidiaries by any “nationally
recognized statistical rating organization,” as such term is defined under Section 3(a)(62) under the Exchange Act and (B) no such organization shall have publicly announced that it has under surveillance or review, or has changed its
outlook with respect to, its rating of the Securities or of any other debt securities or preferred stock issued or guaranteed by the Company or any of its subsidiaries (other than an announcement with positive implications of a possible upgrading).

 (c)    No Material Adverse Change. No event or condition of a type described in Section 3(e) hereof shall
have occurred or shall exist, which event or condition is not described in each of the Time of Sale Information (excluding any amendment or supplement thereto) and the Offering Memorandum (excluding any amendment or

  
 22 

 
supplement thereto) the effect of which in the judgment of the Representative makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities on the terms
and in the manner contemplated by this Agreement, the Time of Sale Information and the Offering Memorandum. 

(d)    Officer’s Certificate. The Representative shall have received on and as of the Closing
Date a certificate of an executive officer of the Company who has specific knowledge of the Company’s financial matters and is satisfactory to the Representative (i) confirming that such officer has carefully reviewed the Time of Sale
Information and the Offering Memorandum and, to the knowledge of such officer, the representations set forth in Sections 3(a) and 3(b) hereof are true and correct, (ii) confirming that the other representations and warranties of the Company and
the Guarantors in this Agreement are true and correct and that the Company and the Guarantors have complied with all agreements and satisfied all conditions on their part to be performed or satisfied hereunder at or prior to the Closing Date and
(iii) to the effect set forth in paragraphs (b) and (c) above. 
 (e)    Comfort Letters. (i) On
the date of this Agreement and on the Closing Date, PricewaterhouseCoopers LLP shall have furnished to the Representative, at the request of the Company, letters, dated the respective dates of delivery thereof and addressed to the Initial
Purchasers, in form and substance reasonably satisfactory to the Representative, containing statements and information of the type customarily included in accountants’ “comfort letters” to underwriters with respect to the financial
statements and certain financial information contained or incorporated by reference in each of the Time of Sale Information and the Offering Memorandum; provided that the letter delivered on the Closing Date shall use a “cut-off” date no more than three business days prior to the Closing Date. 

(ii)    On the Date of this Agreement and on the Closing Date, the Company shall have furnished to the Representative a
certificate, dated the respective dates of delivery thereof and addressed to the Initial Purchasers, of its chief financial officer with respect to certain financial and other data contained in the Time of Sale Information and the Offering
Memorandum, providing “management comfort” with respect to such information, in form and substance reasonably satisfactory to the Representative. 

(f)    Opinion and 10b-5 Statement of Counsel for the Company. Wilson
Sonsini Goodrich & Rosati, Professional Corporation, U.S. counsel for the Company, shall have furnished to the Representative, at the request of the Company, their written opinion and 10b-5 statement,
dated the Closing Date and addressed to the Initial Purchasers, in form and substance reasonably satisfactory to the Representative. 

(g)    Opinion of Local Counsel. De Brauw Blackstone Westbroek N.V., Dutch counsel for the Company, shall have
furnished to the Representative, at the request of the Company, its written opinion, dated the Closing Date and addressed to the Initial Purchasers, in form and substance reasonably satisfactory to the Representative. 

  
 23 

 (h)    Opinion and 10b-5
Statement of Counsel for the Initial Purchasers. The Representative shall have received on and as of the Closing Date an opinion and 10b-5 statement, addressed to the Initial Purchasers, of Davis
Polk & Wardwell LLP, counsel for the Initial Purchasers, with respect to such matters as the Representative may reasonably request, and such counsel shall have received such documents and information as they may reasonably request to enable
them to pass upon such matters. 
 (i)    No Legal Impediment to Issuance. No action shall have been taken and no
statute, rule, regulation or order shall have been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date, prevent the issuance or sale of the Securities; and no injunction
or order of any federal, state or foreign court shall have been issued that would, as of the Closing Date, prevent the issuance or sale of the Securities. 

(j)    Good Standing. The Representative shall have received on and as of the Closing Date satisfactory evidence of
the good standing of the Company and its subsidiaries in their respective jurisdictions of organization and their good standing in such other jurisdictions as the Representative may reasonably request, in each case in writing or any standard form of
telecommunication from the appropriate governmental authorities of such jurisdictions. 
 (k)    DTC. The
Securities shall be eligible for clearance and settlement through DTC. 
 (l)    Indenture and Securities. The
Indenture shall have been duly executed and delivered by a duly authorized officer of the Company and the Trustee, and the Securities shall have been duly executed and delivered by a duly authorized officer of the Company and duly authenticated by
the Trustee. 
 (m)    Additional Documents. On or prior to the Closing Date, the Company shall have furnished to
the Representative such further certificates and documents as the Representative may reasonably request. 
 All opinions, letters,
certificates and evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form and substance reasonably satisfactory to counsel for the Initial Purchasers. 

7.    Indemnification and Contribution. 

(a)    Indemnification of the Initial Purchasers. The Company agrees to indemnify and hold harmless each Initial
Purchaser, its affiliates, directors and officers and each person, if any, who controls such Initial Purchaser within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against any and all losses,
claims, damages and liabilities (including, without limitation, legal fees and other expenses incurred in connection with any suit, action or proceeding or any claim asserted, as such fees and expenses are incurred), joint or several, that arise out
of, or are based upon, any untrue statement or alleged untrue statement of a 

  
 24 

 
material fact contained in the Preliminary Offering Memorandum, any of the other Time of Sale Information, any Issuer Written Communication or the Offering Memorandum (or any amendment or
supplement thereto) or any omission or alleged omission to state therein a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, in each case except insofar as
such losses, claims, damages or liabilities arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to any Initial Purchaser
furnished to the Company in writing by such Initial Purchaser through the Representative expressly for use therein. 

(b)    Indemnification of the Company. Each Initial Purchaser agrees, severally and not jointly, to indemnify and
hold harmless the Company, each of its directors and officers and each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act to the same extent as the indemnity
set forth in paragraph (a) above, but only with respect to any losses, claims, damages or liabilities that arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in
conformity with any information relating to such Initial Purchaser furnished to the Company in writing by such Initial Purchaser through the Representative expressly for use in the Preliminary Offering Memorandum, any of the other Time of Sale
Information, any Issuer Written Communication or the Offering Memorandum (or any amendment or supplement thereto), it being understood and agreed that the only such information consists of the following paragraphs in the Preliminary Offering
Memorandum and the Offering Memorandum in the “Plan of distribution” section: (i) the first sentence of the third paragraph concerning the Initial Purchasers proposing to initially offer the Securities at the initial offering price of
the Securities; (ii) the fourth sentence of the seventh paragraph concerning the intention of the Initial Purchasers to make markets in the Securities after completion of the offering; and (iii) the first and last sentences of the ninth
paragraph concerning overallotment, short positions and stabilizing transactions by the Initial Purchasers. 

(c)    Notice and Procedures. If any suit, action, proceeding (including any governmental or regulatory
investigation), claim or demand shall be brought or asserted against any person in respect of which indemnification may be sought pursuant to either paragraph (a) or (b) above, such person (the “Indemnified Person”) shall
promptly notify the person against whom such indemnification may be sought (the “Indemnifying Person”) in writing; provided that the failure to notify the Indemnifying Person shall not relieve it from any liability
that it may have under paragraph (a) or (b) above except to the extent that it has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and provided, further, that the failure to
notify the Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified Person otherwise than under paragraph (a) or (b) above. If any such proceeding shall be brought or asserted against an Indemnified Person
and it shall have notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably satisfactory to the Indemnified Person (who shall not, without the consent of the Indemnified Person, be counsel to the Indemnifying
Person) to represent the Indemnified Person and any 

  
 25 

 
others entitled to indemnification pursuant to this Section 7 that the Indemnifying Person may designate in such proceeding and shall pay the fees and expenses of such proceeding and shall
pay the fees and expenses of such counsel related to such proceeding, as incurred. In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of
such Indemnified Person unless (i) the Indemnifying Person and the Indemnified Person shall have mutually agreed to the contrary; (ii) the Indemnifying Person has failed within a reasonable time to retain counsel reasonably satisfactory to
the Indemnified Person; (iii) the Indemnified Person shall have reasonably concluded that there may be legal defenses available to it that are different from or in addition to those available to the Indemnifying Person; or (iv) the named
parties in any such proceeding (including any impleaded parties) include both the Indemnifying Person and the Indemnified Person and representation of both parties by the same counsel would be inappropriate due to actual or potential differing
interests between them. It is understood and agreed that the Indemnifying Person shall not, in connection with any proceeding or related proceeding in the same jurisdiction, be liable for the fees and expenses of more than one separate firm (in
addition to any local counsel) for all Indemnified Persons, and that all such fees and expenses shall be paid or reimbursed as they are incurred. Any such separate firm for any Initial Purchaser, its affiliates, directors and officers and any
control persons of such Initial Purchaser shall be designated in writing by J.P. Morgan Securities LLC and any such separate firm for the Company, its directors and officers and any control persons of the Company shall be designated in writing by
the Company. The Indemnifying Person shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the Indemnifying Person agrees to
indemnify each Indemnified Person from and against any loss or liability by reason of such settlement or judgment. No Indemnifying Person shall, without the written consent of the Indemnified Person, effect any settlement of any pending or
threatened proceeding in respect of which any Indemnified Person is or could have been a party and indemnification could have been sought hereunder by such Indemnified Person, unless such settlement (x) includes an unconditional release of such
Indemnified Person, in form and substance reasonably satisfactory to such Indemnified Person, from all liability on claims that are the subject matter of such proceeding and (y) does not include any statement as to or any admission of fault,
culpability or a failure to act by or on behalf of any Indemnified Person. 
 (d)    Contribution. If the
indemnification provided for in paragraph (a) or (b) above is unavailable to an Indemnified Person or insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph,
in lieu of indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or payable by such Indemnified Person as a result of such losses, claims, damages or liabilities (i) in such proportion as is appropriate to reflect
the relative benefits received by the Company on the one hand and the Initial Purchasers on the other from the offering of the Securities or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in such
proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) but also the relative fault of the Company on the one hand and the Initial Purchasers on the other in connection with the

  
 26 

 
statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations. The relative benefits received by the Company on the
one hand and the Initial Purchasers on the other shall be deemed to be in the same respective proportions as the net proceeds (before deducting expenses) received by the Company from the sale of the Securities and the total discounts and commissions
received by the Initial Purchasers in connection therewith, as provided in this Agreement, bear to the aggregate offering price of the Securities. The relative fault of the Company on the one hand and the Initial Purchasers on the other shall be
determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company or by the Initial
Purchasers and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. 

(e)    Limitation on Liability. The Company and the Initial Purchasers agree that it would not be just and
equitable if contribution pursuant to this Section 7 were determined by pro rata allocation (even if the Initial Purchasers were treated as one entity for such purpose) or by any other method of allocation that does not take
account of the equitable considerations referred to in paragraph (d) above. The amount paid or payable by an Indemnified Person as a result of the losses, claims, damages and liabilities referred to in paragraph (d) above shall be deemed
to include, subject to the limitations set forth above, any legal or other expenses incurred by such Indemnified Person in connection with any such action or claim. Notwithstanding the provisions of this Section 7, in no event shall an Initial
Purchaser be required to contribute any amount in excess of the amount by which the total discounts and commissions received by such Initial Purchaser with respect to the offering of the Securities exceeds the amount of any damages that such Initial
Purchaser has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act)
shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Initial Purchasers’ obligations to contribute pursuant to this Section 7 are several in proportion to their respective purchase
obligations hereunder and not joint. 
 (f)    Non-Exclusive Remedies.
The remedies provided for in this Section 7 are not exclusive and shall not limit any rights or remedies that may otherwise be available to any Indemnified Person at law or in equity. 

8.    Effectiveness of Agreement. This Agreement shall become effective as of the date first written above. 

9.    Termination. This Agreement may be terminated in the absolute discretion of the Representative, by notice to
the Company, if after the execution and delivery of this Agreement and on or prior to the Closing Date (i) trading generally shall have been suspended or materially limited on the New York Stock Exchange or the Nasdaq Global Select Market;
(ii) trading of any securities issued or guaranteed by the Company shall have been suspended on any exchange or in any over-the-counter market; (iii) a

  
 27 

 
general moratorium on commercial banking activities shall have been declared by federal or New York State authorities; or (iv) there shall have occurred any outbreak or escalation of
hostilities or any change in financial markets or any calamity or crisis, either within or outside the United States, that, in the judgment of the Representative, is material and adverse and makes it impracticable or inadvisable to proceed with the
offering, sale or delivery of the Securities on the terms and in the manner contemplated by this Agreement, the Time of Sale Information and the Offering Memorandum. 

10.    Defaulting Initial Purchaser. 

(a)    If, on the Closing Date, any Initial Purchaser defaults on its obligation to purchase the Securities that it has
agreed to purchase hereunder, the non-defaulting Initial Purchasers may in their discretion arrange for the purchase of such Securities by other persons satisfactory to the Company on the terms contained in
this Agreement. If, within 36 hours after any such default by any Initial Purchaser, the non-defaulting Initial Purchasers do not arrange for the purchase of such Securities, then the Company shall be entitled
to a further period of 36 hours within which to procure other persons satisfactory to the non-defaulting Initial Purchasers to purchase such Securities on such terms. If other persons become obligated or agree
to purchase the Securities of a defaulting Initial Purchaser, either the non-defaulting Initial Purchasers or the Company may postpone the Closing Date for up to five full business days in order to effect any
changes that in the opinion of counsel for the Company or counsel for the Initial Purchasers may be necessary in the Time of Sale Information, the Offering Memorandum or in any other document or arrangement, and the Company agrees to promptly
prepare any amendment or supplement to the Time of Sale Information or the Offering Memorandum that effects any such changes. As used in this Agreement, the term “Initial Purchaser” includes, for all purposes of this Agreement unless the
context otherwise requires, any person not listed in Schedule 1 hereto that, pursuant to this Section 10, purchases Securities that a defaulting Initial Purchaser agreed but failed to purchase. 

(b)    If, after giving effect to any arrangements for the purchase of the Securities of a defaulting Initial Purchaser or
Initial Purchasers by the non-defaulting Initial Purchasers and the Company as provided in paragraph (a) above, the aggregate principal amount of such Securities that remains unpurchased does not exceed one-eleventh of the aggregate principal amount of all the Securities, then the Company shall have the right to require each non-defaulting Initial Purchaser to purchase the
principal amount of Securities that such Initial Purchaser agreed to purchase hereunder plus such Initial Purchaser’s pro rata share (based on the principal amount of Securities that such Initial Purchaser agreed to purchase
hereunder) of the Securities of such defaulting Initial Purchaser or Initial Purchasers for which such arrangements have not been made. 

(c)    If, after giving effect to any arrangements for the purchase of the Securities of a defaulting Initial Purchaser or
Initial Purchasers by the non-defaulting Initial Purchasers and the Company as provided in paragraph (a) above, the aggregate principal amount of such Securities that remains unpurchased exceeds one-eleventh of 

  
 28 

 
the aggregate principal amount of all the Securities, or if the Company shall not exercise the right described in paragraph (b) above, then this Agreement shall terminate without liability
on the part of the non-defaulting Initial Purchasers. Any termination of this Agreement pursuant to this Section 10 shall be without liability on the part of the Company, except that the Company will
continue to be liable for the payment of expenses as set forth in Section 11 hereof and except that the provisions of Section 7 hereof shall not terminate and shall remain in effect. 

(d)    Nothing contained herein shall relieve a defaulting Initial Purchaser of any liability it may have to the Company
or any non-defaulting Initial Purchaser for damages caused by its default. 

11.    Payment of Expenses. 

(a)    Whether or not the transactions contemplated by this Agreement are consummated or this Agreement is terminated, the
Company agrees to pay or cause to be paid all costs and expenses incident to the performance of their respective obligations hereunder, including without limitation, (i) the costs incident to the authorization, issuance, sale, preparation and
delivery of the Securities and any taxes payable in that connection; (ii) the costs incident to the preparation and printing of the Preliminary Offering Memorandum, any other Time of Sale Information, any Issuer Written Communication and the
Offering Memorandum (including any amendment or supplement thereto) and the distribution thereof; (iii) the costs of reproducing and distributing each of the Transaction Documents; (iv) the fees and expenses of the Company’s counsel
and independent accountants; (v) the fees and expenses incurred in connection with the registration or qualification and determination of eligibility for investment of the Securities under the laws of such jurisdictions as the Representative
may designate and the preparation, printing and distribution of a Blue Sky Memorandum (including the related fees and expenses of counsel for the Initial Purchasers); (vi) any fees charged by rating agencies for rating the Securities;
(vii) the fees and expenses of the Trustee and any paying agent (including related fees and expenses of any counsel to such parties); (viii) all expenses and application fees incurred in connection with the approval of the Securities for
book-entry transfer by DTC; (ix) all expenses incurred by the Company in connection with any “road show” presentation to potential investors. 

(b)    If (i) this Agreement is terminated pursuant to Section 9(ii), (ii) the Company for any reason fails to
tender the Securities for delivery to the Initial Purchasers or (iii) the Initial Purchasers decline to purchase the Securities for any other reason permitted under this Agreement, the Company agrees to reimburse the Initial Purchasers for all out-of-pocket costs and expenses (including the fees and expenses of their counsel) reasonably incurred by the Initial Purchasers in connection with this Agreement and the
offering contemplated hereby. 
 12.    Persons Entitled to Benefit of Agreement. This Agreement shall inure to
the benefit of and be binding upon the parties hereto and their respective successors and the officers and directors and any controlling persons referred to herein, and the affiliates of each Initial Purchaser referred to in Section 7 hereof.
Nothing in this 

  
 29 

 
Agreement is intended or shall be construed to give any other person any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein. No
purchaser of Securities from any Initial Purchaser shall be deemed to be a successor merely by reason of such purchase. 

13.    Survival. The respective indemnities, rights of contribution, representations, warranties and agreements of
the Company and the Initial Purchasers contained in this Agreement or made by or on behalf of the Company or the Initial Purchasers pursuant to this Agreement or any certificate delivered pursuant hereto shall survive the delivery of and payment for
the Securities and shall remain in full force and effect, regardless of any termination of this Agreement or any investigation made by or on behalf of the Company or the Initial Purchasers. 

14.    Certain Defined Terms. For purposes of this Agreement, (a) except where otherwise expressly provided,
the term “affiliate” has the meaning set forth in Rule 405 under the Securities Act; (b) the term “business day” means any day other than a day on which banks are permitted or required to be closed in New York
City; (c) the term “subsidiary” has the meaning set forth in Rule 405 under the Securities Act; (d) the term “Exchange Act” collectively means the Securities Exchange Act of 1934, as amended, and the rules
and regulations of the Commission thereunder; and (e) the term “written communication” has the meaning set forth in Rule 405 under the Securities Act. 

15.    Compliance with USA Patriot Act. In accordance with the requirements of the USA Patriot Act (Title III of
Pub. L. 107-56 (signed into law October 26, 2001)), the Initial Purchasers are required to obtain, verify and record information that identifies their respective clients, including the Company, which
information may include the name and address of their respective clients, as well as other information that will allow the Initial Purchasers to properly identify their respective clients. 

16.    Miscellaneous. 

(a)    Authority of the Representative. Any action by the Initial Purchasers hereunder may be taken by J.P. Morgan
Securities LLC on behalf of the Initial Purchasers, and any such action taken by J.P. Morgan Securities LLC shall be binding upon the Initial Purchasers. 

(b)    Notices. All notices and other communications hereunder shall be in writing and shall be deemed to have been
duly given if mailed or transmitted and confirmed by any standard form of telecommunication. Notices to the Initial Purchasers shall be given to the Representative c/o J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179
(fax: 212-270-1063); Attention: Dave de Boltz, with a copy to Catherine O’Donnell (fax:
917-456-3534). Notices to the Company and shall be given to them at 800 West El Camino Real, Suite 350, Mountain View, CA 94040, Attention: Chief Financial Officer. 

  
 30 

 (c)    Governing Law. This Agreement and any claim, controversy
or dispute arising under or related to this Agreement shall be governed by and construed in accordance with the laws of the State of New York. 

(d)    Submission to Jurisdiction. The Company hereby submits to the exclusive jurisdiction of the U.S. federal and
New York state courts in the Borough of Manhattan in The City of New York in any suit or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. The Company waives any objection which it may now or hereafter
have to the laying of venue of any such suit or proceeding in such courts. The Company agrees that final judgment in any such suit, action or proceeding brought in such court shall be conclusive and binding upon the Company, and may be enforced in
any court to the jurisdiction of which Company is subject by a suit upon such judgment. The Company irrevocably appoints elasticsearch, Inc. 800 West El Camino Real, Suite 350, Mountain View, CA 94040, as its authorized agent upon which process may
be served in any such suit or proceeding, and the Company agrees that service of process upon such agent, and written notice of said service to the Company by the person serving the same to the address provided in Section 16, shall be deemed in
every respect effective service of process upon the Company in any such suit or proceeding. The Company further agrees to take any and all action as may be necessary to maintain such designation and appointment of such agent in full force and effect
for a period of seven years from the date of this Agreement. The Company hereby represents and warrants that such authorized agent has accepted such appointment and has agreed to act as such authorized agent for service of process. The Company
further agrees to take any and all action as may be necessary to maintain such designation and appointment of such authorized agent in full force and effect for a period of seven years from the date of this Agreement. 

(e)    Waiver of Jury Trial. Each of the parties hereto hereby waives any right to trial by jury in any suit or
proceeding arising out of or relating to this Agreement. 
 (f)    Judgment Currency. The Company agrees to
indemnify each Initial Purchaser, its directors, officers, affiliates and each person, if any, who controls such Initial Purchaser within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, against any loss
incurred by such Initial Purchaser as a result of any judgment or order being given or made for any amount due hereunder and such judgment or order being expressed and paid in a currency (the “judgment currency”) other than U.S.
dollars and as a result of any variation as between (i) the rate of exchange at which the U.S. dollar amount is converted into the judgment currency for the purpose of such judgment or order, and (ii) the rate of exchange at which such
indemnified person is able to purchase U.S. dollars with the amount of the judgment currency actually received by the indemnified person. The foregoing indemnity shall constitute a separate and independent obligation of the Company shall continue in
full force and effect notwithstanding any such judgment or order as aforesaid. The term “rate of exchange” shall include any premiums and costs of exchange payable in connection with the purchase of, or conversion into, the relevant
currency. 

  
 31 

 (g)    Waiver of Immunity. To the extent that the Company or any
of its properties, assets or revenues may is or may hereafter become entitled to, or have attributed to them, any right of immunity, on the grounds of sovereignty, from any legal action, suit or proceeding, from
set-off or counterclaim, from the jurisdiction of any court, from service of process, from attachment upon or prior to judgment, or from attachment in aid of execution of judgment, or from execution of
judgment, or other legal process or proceeding for the giving of any relief or for the enforcement of any judgment, in any jurisdiction in which proceedings may at any time be commenced, with respect to its obligations, liabilities or any other
matter under or arising out of or in connection with this Agreement, the Company hereby irrevocably and unconditionally, to the extent permitted by applicable law, waives and agrees not to plead or claim any such immunity and consents to such relief
and enforcement. 
 (h)    Recognition of the U.S. Special Resolution Regimes. 

(i)    In the event that any Initial Purchaser that is a Covered Entity becomes subject to a proceeding
under a U.S. Special Resolution Regime, the transfer from such Initial Purchaser of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S.
Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States. 

(ii)    In the event that any Initial Purchaser that is a Covered Entity or a BHC Act Affiliate of such
Initial Purchaser becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Initial Purchaser are permitted to be exercised to no greater extent than such Default
Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. 

As used in this Section 16(h): 

“BHC Act Affiliate” has the meaning assigned to the term “affiliate” in, and shall be interpreted in accordance with, 12
U.S.C. § 1841(k). 
 “Covered Entity” means any of the following: 

(i) a “covered entity” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b); 

(ii) a “covered bank” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b); or 

(iii) a “covered FSI” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b). 

  
 32 

 “Default Right” has the meaning assigned to that term in, and shall be interpreted
in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1, as applicable. 
 “U.S. Special Resolution Regime” means each of
(i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder. 

(i)    Counterparts. This Agreement may be signed in counterparts (which may include counterparts delivered by any
standard form of telecommunication), each of which shall be an original and all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including any electronic signature covered
by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to
have been duly and validly delivered and be valid and effective for all purposes. 
 (j)    Amendments or
Waivers. No amendment or waiver of any provision of this Agreement, nor any consent or approval to any departure therefrom, shall in any event be effective unless the same shall be in writing and signed by the parties hereto. 

(k)    Headings. The headings herein are included for convenience of reference only and are not intended to be part
of, or to affect the meaning or interpretation of, this Agreement. 
 If the foregoing is in accordance with your understanding, please
indicate your acceptance of this Agreement by signing in the space provided below. 

  
 33 

 
			
	 Very truly yours, 
  

Elastic N.V.

		
	By:	 	 /s/ Janesh Moorjani

		 	Name: Janesh Moorjani
		 	Title: Authorized Representative

  
 [Signature Page to
Purchase Agreement] 

			
	 Accepted: As of the date first written above
  

J.P. MORGAN SECURITIES LLC
  

For itself and on behalf of the
 several Initial Purchasers
listed
 in Schedule 1 hereto.

		
	By:	 	 /s/ Jared Newberry

		 	Authorized Signatory

  
 [Signature Page to
Purchase Agreement] 

 Schedule 1 
  

					
	 Initial Purchaser
	  	Principal Amount	 
	 J.P. Morgan Securities LLC
	  	$	241,500,000	 
	 Morgan Stanley & Co. LLC
	  	$	161,000,000	 
	 Barclays Capital Inc.
	  	$	57,500,000	 
	 BofA Securities, Inc.
	  	$	57,500,000	 
	 Citigroup Global Markets Inc.
	  	$	57,500,000	 
	 Total
	  	$	575,000,000	 

 Schedule 2 

Subsidiaries 
 Elastic Technologies
(Israel) Ltd. 
 Elasticsearch (Beijing) Information Technology Co., Ltd. 

Elasticsearch (CH) AG 
 Elasticsearch AB 

Elasticsearch AS 
 Elasticsearch B.C. Ltd    

 Elasticsearch BV 
 Elasticsearch Federal Inc 

Elasticsearch Finance BV 
 Elasticsearch GmbH 

Elasticsearch HK Ltd 
 Elasticsearch Inc. 

Elasticsearch KK 
 Elasticsearch Korea Limited 

Elasticsearch Ltd 
 Elasticsearch Pte Ltd 

Elasticsearch Pty Ltd 
 Elasticsearch SARL 

Elasticsearch SLU 
 Endgame Inc 

Endgame Systems, LLC 
 OpBeat Inc. 

Opbeat Aps 

 Prelert Inc 

Prelert UK Ltd     
 Swiftype Inc. 

 ANNEX A 

Additional Time of Sale Information 
  

	1.	 Term sheet containing the terms of the Securities, substantially in the form of Annex B. 

 ANNEX B 

Pricing Term Sheet 
 [to
be circulated separately] 

 ANNEX C 

Restrictions on Offers and Sales Outside the United States 

In connection with offers and sales of Securities outside the United States: 

(a)    Each Initial Purchaser acknowledges that the Securities have not been registered under the Securities Act and may
not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons except pursuant to an exemption from, or in transactions not subject to, the registration requirements of the Securities Act. 

(b)    Each Initial Purchaser, severally and not jointly, represents, warrants and agrees that: 

(i)    Such Initial Purchaser has offered and sold the Securities, and will offer and sell the Securities,
(A) as part of their distribution at any time and (B) otherwise until 40 days after the later of the commencement of the offering of the Securities and the Closing Date, only in accordance with Regulation S under the Securities Act
(“Regulation S”) or Rule 144A or any other available exemption from registration under the Securities Act. 

(ii)    None of such Initial Purchaser or any of its affiliates or any other person acting on its or their
behalf has engaged or will engage in any directed selling efforts with respect to the Securities, and all such persons have complied and will comply with the offering restrictions requirement of Regulation S. 

(iii)    At or prior to the confirmation of sale of any Securities sold in reliance on Regulation S, such
Initial Purchaser will have sent to each distributor, dealer or other person receiving a selling concession, fee or other remuneration that purchases Securities from it during the distribution compliance period a confirmation or notice to
substantially the following effect: 
 The Securities covered hereby have not been registered under the U.S. Securities Act of 1933, as
amended (the “Securities Act”), and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons (i) as part of their distribution at any time or (ii) otherwise until 40 days
after the later of the commencement of the offering of the Securities and the date of original issuance of the Securities, except in accordance with Regulation S or Rule 144A or any other available exemption from registration under the Securities
Act. Terms used above have the meanings given to them by Regulation S. 
 (iv)    Such Initial Purchaser has not and
will not enter into any contractual arrangement with any distributor with respect to the distribution of the Securities, except with its affiliates or with the prior written consent of the Company. 

  
 C-1 

 Terms used in paragraph (a) and this paragraph (b) and not otherwise defined in this Agreement
have the meanings given to them by Regulation S. 
 (c)    Each Initial Purchaser acknowledges that no action has been
or will be taken by the Company that would permit a public offering of the Securities, or possession or distribution of any of the Time of Sale Information, the Offering Memorandum, any Issuer Written Communication or any other offering or publicity
material relating to the Securities, in any country or jurisdiction where action for that purpose is required. 

  
 C-2EX-4.4

 Exhibit 4.4 

REGISTRATION RIGHTS AGREEMENT 
 by
and among 
 Traeger, Inc., 

AEA TGP Holdco LP 
 Management
Investors, 
 2594868 Ontario Limited, 

TCP Traeger Holdings SPV LLC 
 and

 THE HOLDERS THAT ARE SIGNATORIES HERETO 

Dated as of [_______], 2021 

 TABLE OF CONTENTS 

 

							
		 		  	 	Page	 
	 Section 1.
	 	Certain Definitions	  	 	3	 
	 Section 2.
	 	Registration Rights	  	 	9	 
		 	2.1. Demand Registrations	  	 	9	 
		 	2.2. Piggyback Registrations	  	 	15	 
		 	2.3. Allocation of Securities Included in Registration Statement	  	 	17	 
		 	2.4. Registration Procedures	  	 	20	 
		 	2.5. Registration Expenses	  	 	28	 
		 	2.6. Certain Limitations on Registration Rights	  	 	28	 
		 	2.7. Limitations on Sale or Distribution of Other Securities	  	 	29	 
		 	2.8. No Required Sale	  	 	30	 
		 	2.9. Indemnification	  	 	30	 
		 	2.10. Limitations on Registration of Other Securities; Representation	  	 	34	 
		 	2.11. No Inconsistent Agreements	  	 	34	 
	 Section 3.
	 	Underwritten Offerings	  	 	34	 
		 	3.1. Requested Underwritten Offerings	  	 	34	 
		 	3.2. Piggyback Underwritten Offerings	  	 	35	 
	 Section 4.
	 	General.	  	 	36	 
		 	4.1. Adjustments Affecting Registrable Securities	  	 	36	 
		 	4.2. Rule 144 and Rule 144A	  	 	36	 
		 	4.3. Nominees for Beneficial Owners	  	 	37	 
		 	4.4. Amendments and Waivers	  	 	37	 
		 	4.5. Notices	  	 	37	 
		 	4.6. Successors and Assigns	  	 	40	 
		 	4.7. Entire Agreement	  	 	40	 
		 	4.8. Governing Law; Jurisdiction; Court Proceedings; Waiver of Jury Trial	  	 	40	 
		 	4.9. Interpretation; Construction	  	 	41	 
		 	4.10. Counterparts	  	 	41	 
		 	4.11. Severability	  	 	41	 
		 	4.12. Remedies	  	 	41	 
		 	4.13. Further Assurances	  	 	41	 
		 	4.14. Confidentiality	  	 	42	 
		 	4.15. IPO	  	 	42	 
		 	4.16. Opt-Out Requests	  	 	43	 

 Schedule 4.5 Notices 
 Exhibit A
Assumption Agreement 

  

 This REGISTRATION RIGHTS AGREEMENT, dated as of [______], 2021 (as amended, restated,
modified or supplemented from time to time, this “Agreement”), by and among (i) Traeger, Inc., a Delaware corporation (the “Company”), (ii) AEA TGP Holdco LP, a Delaware limited partnership, and (iii) each
of the Minority Investors (as defined below). 
 RECITALS: 

WHEREAS, TGP Holdings LP, a Delaware limited partnership, the AEA Investors, the Management Investors (as defined below), the OTPP Investors
(as defined below) and the TCP Investors (as defined below) are parties to that certain Amended and Restated Limited Partnership Agreement of TGP Holdings LP, dated as of September 25, 2017, as amended, restated, modified or supplemented from
time to time (the “Limited Partnership Agreement”), establishing and setting forth their agreement with respect to certain rights and obligations associated with the ownership of TGP Holdings LP, the direct parent of the Company;

 WHEREAS, in connection with entering into the Limited Partnership Agreement, the parties thereto have agreed that the Company shall
provide the registration rights set forth in this Agreement; and 
 WHEREAS, the Company has determined that it is the best interests of the
Company and its stockholders to effect an IPO (as defined below), 
 NOW, THEREFORE, in consideration of the premises and of the mutual
covenants and obligations hereinafter set forth, the parties hereto hereby agree as follows: 
 Section 1. Certain Definitions.
As used herein, the following terms shall have the following meanings: 
 “Additional Piggyback Rights” has the meaning
ascribed to such term in Section 2.2(b). 
 “AEA” means AEA Investors LP, a Delaware limited partnership. 

“AEA Investor” means (i) AEA, (ii) AEA TGP Holdco LP, (iii) any general or limited partnership, corporation or
limited liability company having as a general partner, controlling equity holder or managing member (whether directly or indirectly) a Person who is a general partner, controlling equity holder or managing member (whether directly or indirectly) of
any Person described in clause (i) or (ii) or an Affiliate of such Person and (iv) any Permitted Affiliate Transferee of any of the foregoing that executes an Assumption Agreement; provided, that for the avoidance of doubt, for
purposes of this definition neither “AEA Investors” nor Affiliates thereof shall include any portfolio company of AEA. 

“Affiliate” as applied to any Person, means any other Person directly or indirectly controlling, controlled by, or under
common control with, that Person. For the purposes of this definition “control” (including, with correlative meanings, the terms “controlling,” “controlled by” and “under common control with”), as applied
to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of that Person, whether through the ownership of voting securities (the ownership of more than 50% of the
voting securities of an entity shall for purposes of this definition be deemed to be “control”), by contract or otherwise. For the avoidance of doubt, neither the Company nor any Person controlled by the Company shall be deemed to be
an Affiliate of any Holder. 

  
 3 

 “Agreement” has the meaning ascribed to such term in the Preamble. 

“Assumption Agreement” means an agreement in the form set forth in Exhibit A hereto whereby a Permitted
Affiliate Transferee of a Holder who acquires such Registrable Securities becomes a party to, and agrees to be bound, to the same extent as its transferor, by the terms of this Agreement. For the avoidance of doubt, (i) if the transferor of
such shares was an OTPP Investor or TCP Investor, such transferee will be subject to the same rights and obligations as such OTPP Investor or TCP Investor, as applicable, (ii) if the transferor of such shares was a Management Investor (as
defined below), such transferee will be subject to the same rights and obligations of a Management Investor, or (iii) if the transferor of such shares was an AEA Investor, such transferee will be subject to the same (except as otherwise
provided in such Assumption Agreement) rights and obligations of an AEA Investor. 
 “automatic shelf registration
statement” has the meaning ascribed to such term in Section 2.1(a)(i). 
 “Board” means the Board of
Directors of the Company. 
 “Business Day” means any day excluding Saturday, Sunday and any day which is a legal holiday
under the Laws of the State of New York or the State of Delaware, or is a day on which banking institutions located in the State of New York, the City of New York or the State of Delaware are authorized or required by Law or other governmental
action to close. 
 “Buyer” has the meaning ascribed to such term in the Recitals. 

“Claims” has the meaning ascribed to such term in Section 2.9(a). 

“Common Stock” means all classes of common stock, par value $0.01 per share, of the Company and any and all securities of any
kind whatsoever which may be issued after the date hereof in respect of, or in exchange for, such shares of common stock of the Company pursuant to a merger, consolidation, stock split, stock dividend or recapitalization of the Company or otherwise.

 “Common Stock Equivalents” means, with respect to the Company, all options, warrants and other securities convertible
into, or exchangeable or exercisable for (at any time or upon the occurrence of any event or contingency and without regard to any vesting or other conditions to which such securities may be subject), shares of Common Stock or other equity
securities of the Company (including, without limitation, any note or debt security convertible into or exchangeable for shares of Common Stock or other equity securities of the Company). 

“Company” has the meaning ascribed to such term in the Preamble and, for purposes of this Agreement, such term shall include
any Subsidiary or parent company of Traeger, Inc. and any successor to Traeger, Inc. or any Subsidiary or parent company of Traeger, Inc.. 

“Company Shelf Notice” has the meaning ascribed to such term in Section 2.2(a). 

  
 4 

 “Company Shelf Underwriting” has the meaning ascribed to such term in
Section 2.2(a). 
 “Confidential Information” has the meaning ascribed to such term in Section 4.14. 

“Demand Exercise Notice” has the meaning ascribed to such term in Section 2.1(a)(i). 

“Demand Registration” has the meaning ascribed to such term in Section 2.1(a)(i). 

“Demand Registration Request” has the meaning ascribed to such term in Section 2.1(a)(i). 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the SEC issued under
such Act, as they may from time to time be in effect. 
 “Expenses” means any and all fees and expenses incident to the
Company’s performance of or compliance with Section 2, including, without limitation, (i) SEC, stock exchange, FINRA and all other registration and filing fees and all listing fees and fees with respect to the inclusion of securities
on the New York Stock Exchange, Nasdaq or on any other U.S. or non-U.S. securities market on which the Common Stock is or may be listed or quoted, (ii) fees and expenses of compliance with state
securities or “blue sky” Laws of any state or jurisdiction of the United States or compliance with the securities Laws of foreign jurisdictions and in connection with the preparation of a “blue sky” survey, including, without
limitation, reasonable fees and expenses of outside “blue sky” counsel and securities counsel in foreign jurisdictions, (iii) word processing, printing and copying expenses (including, without limitation, expenses of printing
certificates for the Registrable Securities in a form eligible for deposit with The Depository Trust Company and of printing any prospectus or free writing prospectus), (iv) messenger and delivery expenses, (v) expenses incurred in connection
with any road show, (vi) fees and disbursements of counsel for the Company, (vii) with respect to each registration or underwritten offering, the fees and disbursements of one counsel for the AEA Investors and one counsel for all other
Participating Holder(s) collectively (selected by the holders of a majority of the shares of the Company held by such other Participating Holder(s)), together, in each case, with any local counsel, (viii) fees and disbursements of all
independent public accountants (including the expenses of any audit/review and/or “cold comfort” letter and updates thereof) and fees and expenses of other Persons, including special experts, retained by the Company, (ix) fees and
expenses payable to a Qualified Independent Underwriter (but expressly excluding any underwriting discounts and commissions), (x) fees and expenses of any transfer agent or custodian, (xi) any other (A) fees customarily paid by issuers or
sellers of securities, including fees and disbursements of underwriters, consulting fees and other financial service provider and advisor fees and (B) reasonable fees and expenses of counsel for the underwriters in connection with any filing
with or review by FINRA and (xii) expenses for securities Law liability insurance and, if any, rating agency fees. 

“FINRA” means the Financial Industry Regulatory Authority, Inc. 

“Governance Agreement” means that certain TGP Holdings Corp Governance Agreement, by and among the TGP Holdings Corp and the
parties signatory thereto from time to time. 

  
 5 

 “Governmental Authority” means any federal, state, local, municipal,
foreign or other government or quasi-governmental authority or any department, agency, commission, board, subdivision, bureau, agency, instrumentality, court or other tribunal of any of the foregoing. 

“Holder” or “Holders” means (1) any Person who is a signatory to this Agreement or (2) any
Permitted Affiliate Transferee of Registrable Securities to which any Person who is a signatory to this Agreement shall assign or transfer any rights hereunder, provided, that such transferee has agreed to be bound by the terms of this
Agreement in respect of such Registrable Securities by executing an Assumption Agreement. 
 “Holder Representatives” has
the meaning ascribed to such term in Section 4.14. 
 “Initial Investors” means (i) AEA, AEA TGP Holdco LP,
(ii) Andrus-Traeger Holdings LLC, a Nevada limited liability company, (iii) 2594868 Ontario Limited or (iv) TCP Traeger Holdings SPV LLC, or any of them. 

“Initiating Holders” has the meaning ascribed to such term in Section 2.1(a)(i). 

“IPO” means the initial bona fide underwritten public offering and sale of Common Stock (or other equity securities of the
Company) pursuant to an effective registration statement (other than on Form S-4, S-8 or a comparable form) filed under the Securities Act. 

“Law” means (a) any federal, state, local or foreign constitution, treaty, law, statute, code, regulation, ordinance,
order, decree, rule or other requirement with similar effect of any Governmental Authority (including common or case law) and (b) any judgment, order, writ, injunction, decision, ruling, decree or award of any Governmental Authority. 

“Limited Partnership Agreement” has the meaning ascribed to such term in the Recitals. 

“Litigation” means any claim, action, suit, proceeding, arbitration, or governmental investigation, audit or inquiry. 

“Majority Holders’ Counsel” has the meaning ascribed to such term in Section 2.4(a). 

“Majority Participating Holders” means Participating Holders holding more than 50% of the Registrable Securities proposed to
be included in any offering of Registrable Securities by such Participating Holders pursuant to Section 2.1 or Section 2.2. 

“Management Investors” means Andrus-Traeger Holdings LLC, a Nevada limited liability company. 

“Manager” has the meaning ascribed to such term in Section 2.1(c). 

“Minimum Threshold” means $20 million. 

“Minority Investors” means the Management Investors, the OTPP Investors, the TCP Investors and each Person that executes an
Assumption Agreement or a joinder to this Agreement in form and substance reasonably satisfactory to the Company and the AEA Investors or any of them. 

  
 6 

 “Opt-Out Request” has the meaning
ascribed to such term in Section 4.16. 
 “OTPP Investors” means 2594868 Ontario Limited (or any successor thereof)
and any Permitted Affiliate Transferee of 2594868 Ontario Limited (or any successor thereof) that executes an Assumption Agreement; provided, that, for the avoidance of doubt, for purposes of this definition neither “OTPP Investors”
nor Affiliates thereof shall include any portfolio company of Ontario Teachers’ Pension Plan Board. 
 “Participating
Holders” means all Holders of Registrable Securities which are proposed to be included in any offering of Registrable Securities pursuant to Section 2.1 or Section 2.2. 

“Partner Distribution” has the meaning ascribed to such term in Section 2.1(a)(iii). 

“Permitted Affiliate Transferee” means any Affiliate of any Sponsor Investor or Management Investor to which such Sponsor
Investor or Management Investor, as the case may be, has transferred all or a portion of its Registrable Securities, and which has executed an Assumption Agreement. 

“Person” means any individual, firm, corporation, company, limited liability company, partnership, trust, joint stock
company, business trust, incorporated or unincorporated association or organization, joint venture, governmental authority or other legal entity of any nature whatsoever. 

“Piggyback Notice” has the meaning ascribed to such term in Section 2.2(a). 

“Piggyback Shares” has the meaning ascribed to such term in Section 2.3(a)(iii). 

“Postponement Period” has the meaning ascribed to such term in Section 2.1(b). 

“Purchase Agreement” has the meaning ascribed to such term in the Recitals. 

“Qualified Independent Underwriter” means a “qualified independent underwriter” within the meaning of FINRA Rule
5121. 
 “Registrable Securities” means (a) any shares of Common Stock held by the Holders at any time (including
those held as a result of, or issuable upon, the conversion or exercise of Common Stock Equivalents), whether now owned or acquired by the Holders at a later time, (b) any shares of Common Stock issued or issuable, directly or indirectly, in
exchange for or with respect to the Common Stock referenced in clause (a) above by way of stock dividend, stock split or combination of shares or in connection with a reclassification, recapitalization, merger, share exchange or conversion,
consolidation or other reorganization and (c) any securities issued in replacement of or exchange for any securities described in clause (a) or (b) above. As to any particular Registrable Securities, such securities shall cease to be
Registrable Securities when (A) a registration statement with respect to the sale of such securities shall have been declared effective under the Securities Act and such securities shall have been disposed of in accordance with such
registration statement, (B) such securities shall have been sold in compliance with the requirements of Rule 144 (or any successor provision thereto), (C) such securities have been sold in a private transaction in which the transferor’s
rights under this Agreement are not assigned to the transferee of the securities or (D) such securities have ceased to be outstanding. 

  
 7 

 “Restricted Period” has the meaning ascribed to such term in
Section 2.7(c). 
 “Rule 144” and “Rule 144A” have the meaning
ascribed to such terms in Section 4.2. 
 “SEC” means the U.S. Securities and Exchange Commission or such other
federal agency which at such time administers the Securities Act. 
 “Section 2.3(a) Sale Number” has
the meaning ascribed to such term in Section 2.3(a). 
 “Section 2.3(a)(x) Sale Number” has the
meaning ascribed to such term in Section 2.3(a). 
 “Section 2.3(a) Block Trade Sale Number” has
the meaning ascribed to such term in Section 2.3(a). 
 “Section 2.3(b) Sale Number” has the
meaning ascribed to such term in Section 2.3(b). 
 “Section 2.3(b)(x) Sale Number” has the meaning
ascribed to such term in Section 2.3(b). 
 “Section 2.3(b) Block Trade Sale Number” has the
meaning ascribed to such term in Section 2.3(b). 
 “Section 2.3(c) Sale Number” has the meaning
ascribed to such term in Section 2.3(c). 
 “Section 2.3(c)(x) Sale Number” has the meaning
ascribed to such term in Section 2.3(c). 
 “Section 2.3(c) Block Trade Sale Number” has the
meaning ascribed to such term in Section 2.3(c). 
 “Securities Act” means the Securities Act of 1933, as amended, and
the rules and regulations of the SEC issued under such Act, as they may from time to time be in effect. 
 “Shelf Registrable
Securities” has the meaning ascribed to such term in Section 2.1(e). 
 “Shelf Registration Statement” has
the meaning ascribed to such term in Section 2.1(a)(i). 
 “Shelf Underwriting” has the meaning ascribed to such term
in Section 2.1(e). 
 “Shelf Underwriting Notice” has the meaning ascribed to such term in Section 2.1(e). 

“Shelf Underwriting Request” has the meaning ascribed to such term in Section 2.1(e). 

“Sponsor Investors” means the AEA Investors, the OTTP Investors, the TCP Investors, or any of them. 

  
 8 

 “Subsidiary” means any direct or indirect subsidiary of the Company on the
date hereof and any direct or indirect subsidiary of the Company organized or acquired after the date hereof. 
 “TCP
Investors” means TCP Traeger Holdings SPV LLC, a Delaware limited liability company (or any successor thereof), and any Permitted Affiliate Transferee of TCP Traeger Holdings SPV LLC that executes an Assumption Agreement; provided,
that, for the avoidance of doubt, for purposes of this definition neither “TCP Investors” nor Affiliates thereof shall include any portfolio company of TCP or any of its Affiliates. 

“Underwritten Block Trade” has the meaning ascribed to such term in Section 2.1(e). 

“Units” has the meaning set forth in the Limited Partnership Agreement. 

“Valid Business Reason” has the meaning ascribed to such term in Section 2.1(b). 

“WKSI” has the meaning ascribed to such term in Section 2.1(a)(i). 

Section 2. Registration Rights. 

2.1. Demand Registrations. 

(a) (i) Subject to Sections 2.1(b), 2.1(g) and 2.3, (x) at any time and from time to time any of the AEA Investors shall have the right
to require the Company to file one (1) or more registration statements and (y) at any time and from time to time after the closing of an IPO, each of the OTPP Investors and the TCP Investors shall have the right to require the Company to
file up to two (2) registration statements under the Securities Act covering all or any part of their and their respective Affiliates’ Registrable Securities by delivering a written request therefor to the Company specifying the number of
Registrable Securities to be included in such registration and the intended method of distribution thereof. Any such request by a Sponsor Investor pursuant to this Section 2.1(a)(i) is referred to herein as a “Demand Registration
Request,” and the registration so requested is referred to herein as a “Demand Registration” (with respect to any Demand Registration, the Sponsor Investor(s) making such demand for registration being referred to as the
“Initiating Holders”). The AEA Investors shall be entitled to request (and the Company shall be required to effect) an unlimited number of Demand Registrations and, after the closing of an IPO, each of the OTPP Investors and the TCP
Investors shall be entitled to request (and the Company shall be required to effect) up to two (2) Demand Registrations (in each case, it being understood that if a single Demand Registration Request is delivered by more than one Initiating
Holder, the registration requested by such Demand Registration Request shall constitute only one Demand Registration). Any Demand Registration Request made after the closing of an IPO may request that the Company register Registrable Securities on
an appropriate form, including a shelf registration statement pursuant to Rule 415 under the Securities Act on Form S-3 (if the Company is eligible to file a shelf registration statement on Form S-3) or Form S-1 (any such shelf registration statement on Form S-3 or Form S-1, a
“Shelf Registration Statement”), and, if the Company is a well-known seasoned issuer (as defined in Rule 405 under the Securities Act, a “WKSI”), an automatic shelf registration statement (as defined in Rule
405 under the Securities Act (an “automatic shelf registration statement”). The Company shall give written notice (the “Demand Exercise Notice”) of such Demand Registration Request (1) to each Holder of

  
 9 

 
Registrable Securities (other than individuals) at least five (5) Business Days prior to the filing of any registration statement under the Securities Act and (2) to each Holder of
Registrable Securities that is an individual, no more than five (5) Business Days after the filing of the registration statement under the Securities Act (or, in the case of a request for the filing of an automatic shelf registration statement,
at least five (5) Business Days prior to the filing of such registration statement). Notwithstanding the foregoing, the Company may delay any Demand Exercise Notice, including until after filing a registration statement, so long as all
recipients of such notice have the same amount of time to determine whether to participate in an offering as they would have had if such notice had not been so delayed. 

(ii) The Company, subject to Sections 2.3 and 2.6, shall include in a Demand Registration (x) the Registrable Securities of the
Initiating Holders and (y) the Registrable Securities of any other Holder of Registrable Securities which shall have made a written request to the Company for inclusion in such registration pursuant to Section 2.2 (which request shall
specify the maximum number of Registrable Securities intended to be disposed of by such Participating Holder) within five (5) days following the receipt of any such Demand Exercise Notice. 

(iii) The Company shall, as expeditiously as possible, but subject to Section 2.1(b), use its reasonable best efforts to
(x) file with the SEC (no later than forty-five (45) days from the Company’s receipt of the applicable Demand Registration Request) and cause to be declared effective such registration under the Securities Act as soon as reasonably
practicable (including, without limitation, by means of a shelf registration pursuant to Rule 415 under the Securities Act if so requested and if the Company is then eligible to use such a registration) of the Registrable Securities which the
Company has been so requested to register, for distribution in accordance with the intended method of distribution, including a distribution to, and registered resale by, the members, partners or other equity holders of a Holder (a “Partner
Distribution”) and (y) if requested by the Initiating Holders, obtain acceleration of the effective date of the registration statement relating to such registration. 

(iv) Notwithstanding anything contained herein to the contrary, the Company shall, at the request of any Holder seeking to effect or
considering a Partner Distribution, file any prospectus supplement or post-effective amendments, or include in the initial registration statement any disclosure or language, or include in any prospectus supplement or post-effective amendment any
disclosure or language, and otherwise take any action, deemed necessary or advisable by such Holder to effect such Partner Distribution. 

(b) Notwithstanding anything to the contrary in Section 2.1(a), the Demand Registration rights granted in Section 2.1(a) are subject
to the following limitations: (i) the Company shall not be required to cause a registration pursuant to Section 2.1(a) to be declared effective within a period of ninety (90) days after the effective date of any other registration of
the Company (or one hundred eighty (180) days in the case of an IPO) filed pursuant to the Securities Act (other than a Form S-4 or Form S-8 or any successor or
other forms promulgated for similar purposes or forms filed in connection with an exchange offer or any employee benefit or dividend reinvestment plan); (ii) each registration in respect of a Demand Registration Request made by any Holder must
include, in the aggregate, Registrable Securities having an aggregate market value of at least the lesser of (a) the Minimum Threshold (based on the Registrable Securities included 

  
 10 

 
in such registration by all Holders participating in such registration) and (b) the market value of the Initiating Holder’s remaining Registrable Securities; and (iii) if the
Board, in its good faith judgment, determines that any registration of Registrable Securities should not be made or continued because it would materially and adversely interfere with any existing or potential material financing, acquisition,
corporate reorganization, merger, share exchange or other transaction or event involving the Company or any of its Subsidiaries or because the Company does not yet have appropriate financial statements of the Company or any acquired or to be
acquired entities available for filing (in each case, a “Valid Business Reason”), then (x) the Company may postpone filing a registration statement relating to a Demand Registration Request until five (5) Business Days
after such Valid Business Reason no longer exists, but in no event for more than forty-five (45) days after the date the Board determines a Valid Business Reason exists and (y) in case a registration statement has been filed relating to a
Demand Registration Request, the Company may, to the extent determined in the good faith judgment of the Board to be reasonably necessary to avoid interference with any of the transactions described above, suspend use of or, if required by the SEC,
cause such registration statement to be withdrawn and its effectiveness terminated or may postpone amending or supplementing such registration statement until five (5) Business Days after such Valid Business Reason no longer exists, but in no
event for more than forty-five (45) days after the date the Board determines a Valid Business Reason exists (such period of postponement or withdrawal under this clause (iii), the “Postponement Period”). The Company shall give
written notice to the Initiating Holders and any other Holders that have requested registration pursuant to Sections 2.1(a)(ii) or 2.2 of its determination to postpone or suspend use of or withdraw a registration statement and of the fact that the
Valid Business Reason for such postponement or suspension or withdrawal no longer exists, in each case, promptly after the occurrence thereof; provided, however, the Company shall not be permitted to postpone or suspend use of or
withdraw a registration statement after the expiration of any Postponement Period until twelve (12) months after the expiration of such Postponement Period. 

If the Company shall give any notice of postponement or suspension or withdrawal of any registration statement pursuant to clause
(iii) above, the Company shall not, during the Postponement Period, register any Common Stock, other than pursuant to a registration statement on Form S-4 or S-8
(or an equivalent registration form then in effect). Each Holder of Registrable Securities agrees that, upon receipt of any notice from the Company that the Company has determined to suspend use of, withdraw, terminate or postpone amending or
supplementing any registration statement pursuant to clause (iii) above, such Holder will discontinue its disposition of Registrable Securities pursuant to such registration statement. If the Company shall have suspended use of, withdrawn or
terminated a registration statement filed under Section 2.1(a)(i) (whether pursuant to clause (iii) above or as a result of any stop order, injunction or other order or requirement of the SEC or any other governmental agency or court), the
Company shall not be considered to have effected a Demand Registration for the purposes of this Agreement until the Company shall have permitted use of such suspended registration statement or filed a new registration statement covering the
Registrable Securities covered by the withdrawn or terminated registration statement and such registration statement shall have been declared effective and shall not have been withdrawn. If the Company shall give any notice of suspension, withdrawal
or postponement of a registration statement, the Company shall, not later than five (5) Business Days after the Valid Business Reason that caused such suspension, withdrawal or postponement no longer exists (but in no event later than
forty-five (45) days after the date of the suspension, postponement or withdrawal), as applicable, permit use of such suspended registration statement 

  
 11 

 
or use its reasonable best efforts to effect the registration under the Securities Act of the Registrable Securities covered by the withdrawn or postponed registration statement in accordance
with this Section 2.1 (unless the Initiating Holders shall have withdrawn such request, in which case the Company shall not be considered to have effected a Demand Registration for purposes of this Agreement and such request shall not count as
a Demand Registration Request under this Agreement), and following such permission or such effectiveness such registration shall no longer be deemed to be suspended, withdrawn or postponed pursuant to clause (iii) of Section 2.1(b) above.

 (c) In connection with any Demand Registration (including any Shelf Underwriting or Underwritten Block Trade), the AEA Investors shall
have the right to designate the lead managing underwriter (any lead managing underwriter for the purposes of this Agreement, the “Manager”) in connection with any underwritten offering pursuant to such registration and each other
managing underwriter for any such underwritten offering; provided that in each case (other than an Underwritten Block Trade), each such underwriter is reasonably satisfactory to the Company, which approval shall not be unreasonably withheld,
conditioned or delayed. 
 (d) No Demand Registration shall be deemed to have occurred for purposes of Section 2.1(a) (i)
if the registration statement relating thereto (x) does not become effective, (y) is not maintained effective for a period of at least one hundred eighty (180) days after the effective date thereof (or, with respect to a Shelf
Registration Statement, three (3) years) or such shorter period during which all Registrable Securities included in such registration statement have actually been sold (provided, however, that such period shall be extended for a
period of time equal to the period during which the Holders of Registrable Securities refrain from selling any securities included in such registration statement at the request of the Company or an underwriter of the Company) or (z) is subject
to a stop order, injunction, or similar order or requirement of the SEC during such period, (ii) if the method of disposition is a firm commitment underwritten public offering and any of the applicable Registrable Securities have not been sold
pursuant thereto or (iii) if the conditions to closing specified in any underwriting agreement, purchase agreement or similar agreement entered into in connection with the registration relating to such request are not satisfied (other than as a
result of a default or breach thereunder by the Initiating Holders) or are otherwise not waived by the Initiating Holders. 
 (e) Upon a
Demand Registration Request made in accordance with Section 2.1(a), at any time following such time as the Company shall have become eligible to file a Shelf Registration Statement on Form S-3 in
accordance with Rule 415 under the Securities Act, (i) the Company shall use its best efforts to file a Shelf Registration Statement on Form S-3 in accordance with Rule 415 under the Securities Act and to
effect and maintain in effect a Shelf Registration Statement on Form S-3 in accordance with this Section 2.1(e) (including, if requested by a Sponsor Investor, filing a replacement registration statement
upon expiration of such Shelf Registration Statement), (ii) such Shelf Registration Statement shall provide for an offer to be made on a continuous basis pursuant to Rule 415 under the Securities Act relating to the offer and sale, from time to
time, of all of those Registrable Securities held by the Sponsor Investors and Management Investors that are requested to be registered on such Shelf Registration Statement and (iii) the Sponsor Investors and Management Investors shall have the
right at any time and from time to time to elect (without limitation on the number of such elections) to sell pursuant to an underwritten offering Registrable Securities available for sale pursuant to such Shelf Registration Statement.

  
 12 

 
Any of the Sponsor Investors or Management Investors may make such election to sell Registrable Securities by delivering to the Company a written request (a “Shelf Underwriting
Request”) for such underwritten offering specifying the number of Registrable Securities that such Sponsor Investor or Management Investor, as the case may be, desires to sell pursuant to such underwritten offering (the “Shelf
Underwriting”). As promptly as practicable, but no later than two (2) Business Days after receipt of a Shelf Underwriting Request, the Company shall give written notice (the “Shelf Underwriting Notice”) of such Shelf
Underwriting Request to the Holders of record of other Registrable Securities registered on such Shelf Registration Statement (“Shelf Registrable Securities”). The Company, subject to Sections 2.3 and 2.6, shall include in such
Shelf Underwriting Notice (x) the Registrable Securities of the Sponsor Investors and Management Investors, as applicable, making such Shelf Underwriting Request and (y) the Shelf Registrable Securities of any other Holder of Shelf
Registrable Securities which shall have made a written request to the Company for inclusion in such Shelf Underwriting (which request shall specify the maximum number of Shelf Registrable Securities intended to be disposed of by such Holder) within
five (5) days after the receipt of the Shelf Underwriting Notice. The Company shall, as expeditiously as possible (and in any event within twenty (20) days after the receipt of a Shelf Underwriting Request), but subject to
Section 2.1(b), use its reasonable best efforts to facilitate such Shelf Underwriting. Notwithstanding the foregoing, if any Sponsor Investor wishes to engage in an underwritten block trade or similar transaction or other transaction with a 2-day or less marketing period (collectively, “Underwritten Block Trade”) pursuant to a Shelf Registration Statement (either through filing an automatic shelf registration statement or through a
take-down from an already effective Shelf Registration Statement), then notwithstanding the foregoing time periods, such Sponsor Investor only needs to notify the Company of the Underwritten Block Trade two (2) Business Days prior to the day
such Underwritten Block Trade is to commence, and the Company shall notify the other Sponsor Investors (in each case, if then a Holder of Registrable Securities) on the same day, and such other Sponsor Investors, as applicable, must elect whether or
not to participate by the next Business Day (i.e., one (1) Business Day prior to the date such offering is to commence), and the Company shall as expeditiously as possible, but subject to Section 2.1(b), use its reasonable best efforts to
facilitate such Underwritten Block Trade (which may close as early as two (2) Business Days after the date it commences); provided, however, that the Sponsor Investor requesting such Underwritten Block Trade shall use commercially
reasonable efforts to work with the Company and the underwriters prior to making such request in order to facilitate preparation of the registration statement (including, if applicable, filing an automatic shelf registration statement), prospectus
and other offering documentation related to the Underwritten Block Trade. In the event any Sponsor Investor requests such an Underwritten Block Trade, notwithstanding anything to the contrary in this Section 2.1 or in Section 2.2, no
Management Investor, and no other Holder that is not an Initial Investor or a Permitted Affiliate Transferee of an Initial Investor, shall have any right to notice of or to participate in such Underwritten Block Trade at any time. The Company shall,
at the request of any Sponsor Investor or Management Investor requesting a Shelf Underwriting, or any Sponsor Investor requesting an Underwritten Block Trade, file any prospectus supplement or, if the applicable Shelf Registration Statement is an
automatic shelf registration statement, any post-effective amendments and otherwise take any action necessary to include therein all disclosure and language deemed necessary or advisable by such requesting Holder(s) or any other Holder of Shelf
Registrable Securities to effect such Shelf Underwriting or Underwritten Block Trade, as applicable. Notwithstanding anything to the contrary in this Section 2.1(e), once a Shelf Registration 

  
 13 

 
Statement has been declared effective, with respect to such Shelf Registration Statement (i) the AEA Investors may request, and the Company shall be required to facilitate, subject to
Section 2.1(b), an unlimited number of Shelf Underwritings and Underwritten Block Trades, (ii) each of the OTPP Investors and the TCP Investors may request, and the Company shall be required to facilitate, subject to Sections 2.1(b),
2.1(g) and 2.7(c), an unlimited number of Shelf Underwritings and Underwritten Block Trades, provided, however, that there shall be no more than one Shelf Underwriting or Underwritten Block Trade requested by the OTPP Investors or the
TCP Investors, as applicable, in any period of six (6) consecutive months without the prior written consent of the Board (which consent shall not be unreasonably withheld) and (iii) the Management Investors may request, and the Company
shall be required to facilitate, subject to Sections 2.1(b) and 2.7(c), an unlimited number of Shelf Underwritings, provided, however, that there shall be no more than one Shelf Underwriting requested by the Management Investors in any
period of six (6) consecutive months without the prior written consent of the Board. For the avoidance of doubt, no Minority Investor that is not a Sponsor Investor shall have any right to request or to participate in any Underwritten Block
Trade, as applicable, pursuant to this Agreement. Notwithstanding anything to the contrary in this Section 2.1(e), each Shelf Underwriting and Underwritten Block Trade must include, in the aggregate, Registrable Securities having an aggregate
market value of at least the lesser of (a) the Minimum Threshold (based on the Registrable Securities included in such Shelf Underwriting or Underwritten Block Trade by all Holders participating in such Shelf Underwriting or Underwritten Block
Trade) and (b) the market value of the remaining Registrable Securities held by the Holder requesting such Shelf Underwriting or Underwritten Block Trade, as applicable. 

(f) Any Initiating Holder may withdraw or revoke a Demand Registration Request delivered by such Initiating Holder at any time prior to the
effectiveness of such Demand Registration and such Demand Registration shall have no further force or effect and such request shall not count as a Demand Registration Request under this Agreement. The Company may, at its election, give written
notice of such withdrawal or revocation to each Holder and thereupon will be relieved of its obligation to register any Registrable Securities in connection with such Demand Registration. 

(g) The right of the OTPP Investors to request any Demand Registration (including any Shelf Underwriting or Underwritten Block Trade) pursuant
to this Section 2.1 shall apply only for so long as each of such entities, together with their respective Affiliates, continue to hold at least 25.0% of the Units that 2594868 Ontario Limited held as of September 25, 2017 (or any equity
securities into which such Units were exchanged or converted); provided, however, that following such time, subject to Sections 2.1(b) and 2.7(c), the OTPP Investors may request, and the Company shall be required to facilitate, one
(1) Underwritten Block Trade pursuant to an existing Shelf Registration Statement; provided, further, that if there is no existing Shelf Registration Statement covering the Registrable Securities of the OTPP Investors available at
such time, then the OTPP Investors may request, and the Company shall be required to facilitate, one (1) Demand Registration, subject to Sections 2.1(b) and 2.7(c); provided, however, that the OTPP Investors may request no more than two
(2) Demand Registrations in the aggregate for any purpose pursuant this Section 2.1. The right of the TCP Investors to request any Demand Registration (including any Shelf Underwriting or Underwritten Block Trade) pursuant to this
Section 2.1 shall apply only for so long as each of such entities, together with their respective Affiliates, continue to hold at least 25.0% of the Units that TCP Traeger Holdings SPV LLC held as of September 25, 2017 (or any equity
securities into which such Units were exchanged or converted); provided, however, that 

  
 14 

 
following such time, subject to Sections 2.1(b) and 2.7(c), the TCP Investors may request, and the Company shall be required to facilitate, one (1) Underwritten Block Trade pursuant to an
existing Shelf Registration Statement; provided, further, that if there is no existing Shelf Registration Statement covering the Registrable Securities of the TCP Investors available at such time, then the TCP Investors may request,
and the Company shall be required to facilitate, one (1) Demand Registration, subject to Sections 2.1(b) and 2.7(c); provided, however, that the TCP Investors may request no more than two (2) Demand Registrations in the aggregate
for any purpose pursuant this Section 2.1. The right of the Management Investors to request any Shelf Underwriting pursuant to this Section 2.1 shall apply only for so long as each of such entities, together with their respective
Affiliates, continue to hold at least 25.0% of the Units that Andrus-Traeger Holdings LLC held as of September 25, 2017 (or any equity securities into which such Units were exchanged or converted). 

2.2. Piggyback Registrations. 

(a) If the Company proposes or is required (pursuant to Section 2.1 or otherwise) to register any of its equity securities for its own
account or for the account of any other shareholder under the Securities Act (other than pursuant to registrations on Form S-4 or Form S-8 or any similar successor forms
thereto), the Company shall give written notice (the “Piggyback Notice”) of its intention to do so (1) to the Sponsor Investors and Management Investors promptly after deciding to undertake such registration (and in no event
more than five (5) Business Days thereafter), (2) to each of the other Holders of Registrable Securities (other than individuals), at least five (5) Business Days prior to the filing of any registration statement under the Securities Act
and (3) to each Holder of Registrable Securities that is an individual, no more than five (5) Business Days after the filing of the registration statement under the Securities Act (or, in the case of an automatic shelf registration
statement, at least five (5) Business Days prior to the filing of such registration statement). Notwithstanding the foregoing, the Company may delay any Piggyback Notice to any Holders of Registrable Securities, including until after filing a
registration statement, so long as all recipients of such notice have the same amount of time to determine whether to participate in an offering as they would have had if such notice had not been so delayed. Upon the written request of any such
Holder, made within five (5) days following the receipt of any such Piggyback Notice (which request shall specify the maximum number of Registrable Securities intended to be disposed of by such Holder and the intended method of distribution
thereof), the Company shall, subject to Sections 2.2(c), 2.2(f), 2.3 and 2.6 hereof, use its reasonable best efforts to cause all such Registrable Securities, the Holders of which have so requested the registration thereof, to be registered under
the Securities Act with the securities which the Company at the time proposes to register to permit the sale or other disposition by the Holders (in accordance with the intended method of distribution thereof) of the Registrable Securities to be so
registered, including, if necessary, by filing with the SEC a post-effective amendment or a supplement to the registration statement filed by the Company or the prospectus related thereto. There is no limitation on the number of such piggyback
registrations pursuant to the preceding sentence which the Company is obligated to effect. No registration of Registrable Securities effected under this Section 2.2(a) shall relieve the Company of its obligations to effect Demand Registrations
under Section 2.1 hereof. If the Company proposes or is required (pursuant to Section 2.1 or otherwise) to sell pursuant to an underwritten offering Registrable Securities available for sale pursuant to a Shelf Registration Statement (the
“Company Shelf Underwriting”), the Company shall, as promptly as practicable, give written notice of such Company Shelf 

  
 15 

 
Underwriting (the “Company Shelf Notice”) to each Holder of Shelf Registrable Securities. In addition to any equity securities that the Company proposes to sell for its own
account in such Company Shelf Underwriting, the Company shall, subject to Sections 2.3 and 2.6, include in such Company Shelf Underwriting the Shelf Registrable Securities of any other Holder of Shelf Registrable Securities which shall
have made a written request to the Company for inclusion in such Company Shelf Underwriting (which request shall specify the maximum number of Shelf Registrable Securities intended to be disposed of by such Holder) within five (5) days after
the receipt of the Company Shelf Notice. Notwithstanding the foregoing, (x) if the Company wishes to engage in an Underwritten Block Trade pursuant to a Shelf Registration Statement (a “Company Underwritten Block Trade”), then
notwithstanding the foregoing time periods, the Company only needs to notify the Sponsor Investors (in each case, if such Sponsor Investor is then a Holder of Registrable Securities) of the Company Underwritten Block Trade two (2) Business Days
prior to the day such Company Underwritten Block Trade is to commence and such Sponsor Investor must elect whether or not to participate by the next Business Day (i.e., one (1) Business Day prior to the date such Company Underwritten Block
Trade is to commence), and the Company shall as expeditiously as possible use its reasonable best efforts to facilitate such Company Underwritten Block Trade (which may close as early as two (2) Business Days after the date it commences), and
(y) if a Sponsor Investor wishes to engage in an Underwritten Block Trade pursuant to a Shelf Registration Statement, then the provisions set forth in Section 2.1(e) shall apply to such Underwritten Block Trade. In the event the Company or
a Sponsor Investor requests a Company Underwritten Block Trade or an Underwritten Block Trade, notwithstanding anything to the contrary in Section 2.1 or in this Section 2.2, no Management Investor, and no other Investor that is not an
Initial Investor or a Permitted Affiliate Transferee of an Initial Investor, shall have any right to notice of or to participate in such Company Underwritten Block Trade or Underwritten Block Trade at any time. 

(b) The Company, subject to Sections 2.3 and 2.6, may elect to include in any registration statement and offering pursuant to demand
registration rights by any Person or otherwise, (i) authorized but unissued shares of Common Stock or shares of Common Stock held by the Company as treasury shares and (ii) any other shares of Common Stock which are requested to be
included in such registration pursuant to the exercise of piggyback registration rights granted by the Company after the date hereof and which are not inconsistent with the rights granted in, or otherwise conflict with the terms of, this Agreement
(“Additional Piggyback Rights”); provided, however, that, with respect to any underwritten offering, including a block trade, such inclusion shall be permitted only to the extent that it is pursuant to, and subject to,
the terms of the underwriting agreement or arrangements, if any, entered into by (i) the AEA Investors, to the extent that no other participating Holder is selling a greater number of Registrable Securities than the AEA Investors in such
underwritten offering, or, otherwise, (ii) the Majority Participating Holders in such underwritten offering. 
 (c) Other than in
connection with a Demand Registration, if, at any time after giving a Piggyback Notice (or a Company Shelf Notice) and prior to the effective date of the registration statement filed in connection with such registration (or the sale pursuant to a
Company Shelf Underwriting), the Company shall determine for any reason not to register (or sell) or to delay registration (or sale) of such equity securities, the Company may, at its election, give written notice of such determination to all
Holders of record of Registrable Securities and (i) in the case of a determination not to register (or sell), shall be relieved of its obligation to register (or sell) any 

  
 16 

 
Registrable Securities in connection with such abandoned registration (or abandoned sale), without prejudice, however, to the rights of Holders under Section 2.1, and (ii) in the case
of a determination to delay such registration (or sale) of its equity securities, shall be permitted to delay the registration (or sale) of such Registrable Securities for the same period as the delay in registering (or selling) such other equity
securities. 
 (d) Any Holder shall have the right to withdraw its request for inclusion of its Registrable Securities in any registration
statement or offering pursuant to this Section 2.2 by giving written notice to the Company of its request to withdraw; provided, however, that such request must be made in writing prior to the earlier of the execution of the
underwriting agreement or the execution of the custody agreement with respect to such registration or offering or as otherwise required by the underwriters. 

(e) Notwithstanding anything contained herein to the contrary, the Company shall, at the request of any Holder (including to effect a Partner
Distribution), file any prospectus supplement or post-effective amendments, or include in the initial registration statement any disclosure or language, or include in any prospectus supplement or post-effective amendment any disclosure or language,
and otherwise take any action, deemed necessary or advisable by such Holder (including to effect such Partner Distribution). 
 (f)
Notwithstanding anything contained herein to the contrary, the piggyback registration rights set forth in Sections 2.1(a)(i) or 2.2(a) shall not apply to any Holder in connection with an IPO without the prior written consent of the AEA Investors;
provided, however, that if the AEA Investors participate in such IPO, each Holder of Registrable Securities that is an Initial Investor (other than an AEA Investor), or a Permitted Affiliate Transferee of such Initial Investor, shall
be entitled to participate in such IPO on a pro rata basis in accordance with the provisions of this Section 2.2, subject to Sections 2.3 and 2.6 hereof. 

2.3. Allocation of Securities Included in Registration Statement. 

(a) If any requested registration or offering made pursuant to Section 2.1 (including a Shelf Underwriting) involves (x) an
underwritten offering and the Manager of such offering shall advise the Company that, in its view, the number of securities requested to be included in such underwritten offering by the Holders of Registrable Securities, the Company or any other
Persons exercising Additional Piggyback Rights exceeds the largest number (the “Section 2.3(a)(x) Sale Number”) that can be sold in an orderly manner in such underwritten offering within a price range acceptable
to (i) the AEA Investors, to the extent that no other participating Holder is selling a greater number of Registrable Securities than the AEA Investors in such underwritten offering, or, otherwise, (ii) the Majority Participating Holders
or (y) an Underwritten Block Trade and the number of securities requested to be included in such Underwritten Block Trade by the Sponsor Investors or any other Persons exceeds the number that are sold in any such Underwritten Block Trade (the
“Section 2.3(a) Block Trade Sale Number” and, together with the Section 2.3(a)(x) Sale Number, the “Section 2.3(a) Sale Number”), the Company shall use its reasonable best
efforts to include in such underwritten offering: 

  
 17 

 (i) first, all Registrable Securities requested to be included in such underwritten offering
by the Holders thereof (including pursuant to the exercise of piggyback rights pursuant to Section 2.2); provided, however, that if the number of such Registrable Securities exceeds the Section 2.3(a) Sale Number, the number
of such Registrable Securities (not to exceed the Section 2.3(a) Sale Number) to be included in such underwritten offering shall be allocated on a pro rata basis among all Holders requesting that Registrable Securities be included in such
underwritten offering (including pursuant to the exercise of piggyback rights pursuant to Section 2.2), based on the number of Registrable Securities then owned by each such Holder requesting inclusion in relation to the aggregate number of
Registrable Securities owned by all Holders requesting inclusion; 
 (ii) second, to the extent that the number of Registrable Securities to
be included pursuant to clause (i) of this Section 2.3(a) is less than the Section 2.3(a) Sale Number, any securities that the Company proposes to register or sell, up to the Section 2.3(a) Sale Number; and 

(iii) third, to the extent that the number of Registrable Securities to be included pursuant to clauses (i) and (ii) of this
Section 2.3(a) is less than the Section 2.3(a) Sale Number, the remaining Registrable Securities to be included in such underwritten offering shall be allocated on a pro rata basis among all Persons requesting that securities be included
in such underwritten offering pursuant to the exercise of Additional Piggyback Rights (“Piggyback Shares”), based on the number of Piggyback Shares then owned by each Person requesting inclusion in relation to the aggregate number
of Piggyback Shares owned by all Persons requesting inclusion, up to the Section 2.3(a) Sale Number. 
 Notwithstanding anything in
this Section 2.3(a) to the contrary, neither any employee stockholder of the Company nor any Management Investor (for so long as Jeremy Andrus is an employee of the Company or any of its Affiliates) will be entitled to include Registrable
Securities in an underwritten offering requested by any Initiating Holder pursuant to Section 2.1 to the extent that the Manager of such underwritten offering shall determine in good faith that the participation of such employee stockholder, or
such Management Investor, as applicable, would adversely affect the marketability of the securities being sold by such Initiating Holder in such underwritten offering. 

(b) If any registration or offering made pursuant to Section 2.2 (including a Shelf Underwriting) involves (x) an underwritten
primary offering on behalf of the Company after the date hereof and the Manager shall advise the Company that, in its view, the number of securities requested to be included in such underwritten offering by the Holders of Registrable Securities, the
Company or any other Persons exercising Additional Piggyback Rights exceeds the largest number (the “Section 2.3(b)(x) Sale Number”) that can be sold in an orderly manner in such underwritten offering within a
price range acceptable to the Company or (y) a Company Underwritten Block Trade and the number of securities requested to be included in such Company Underwritten Block Trade by the Company, the Sponsor Investors or any other Persons exceeds
the number that are sold in any such Company Underwritten Block Trade (the “Section 2.3(b) Block Trade Sale Number” and, together with the Section 2.3(b)(x) Sale Number, the
“Section 2.3(b) Sale Number”), the Company shall use its reasonable best efforts to include in such underwritten offering: 

(i) first, all equity securities that the Company proposes to register or sell for its own account; 

  
 18 

 (ii) second, to the extent that the number of Registrable Securities to be included pursuant
to clause (i) of this Section 2.3(b) is less than the Section 2.3(b) Sale Number, the remaining Registrable Securities to be included in such underwritten offering shall be allocated on a pro rata basis among all Holders requesting
that Registrable Securities be included in such underwritten offering pursuant to the exercise of piggyback rights pursuant to Section 2.2(a), based on the number of Registrable Securities then owned by each such Holder requesting inclusion in
relation to the aggregate number of Registrable Securities owned by all Holders requesting inclusion, up to the Section 2.3(b) Sale Number; and 

(iii) third, to the extent that the number of Registrable Securities to be included pursuant to clauses (i) and (ii) of this
Section 2.3(b) is less than the Section 2.3(b) Sale Number, the remaining Registrable Securities to be included in such underwritten offering shall be allocated on a pro rata basis among all Persons requesting that securities be included
in such underwritten offering pursuant to the exercise of Additional Piggyback Rights, based on the number of Piggyback Shares then owned by each Person requesting inclusion in relation to the aggregate number of Piggyback Shares owned by all
Persons requesting inclusion, up to the Section 2.3(b) Sale Number. 
 Notwithstanding anything in this Section 2.3(b) to the
contrary, neither any employee stockholder of the Company nor any Management Investor (for so long as Jeremy Andrus is an employee of the Company or any of its Affiliates) will be entitled to include Registrable Securities in an underwritten
offering of the Company pursuant to Section 2.2 to the extent that the Manager of such underwritten offering shall determine in good faith that the participation of such employee stockholder, or such Management Investor, as applicable, would
adversely affect the marketability of the securities being sold by the Company in such underwritten offering. 
 (c) If any registration
pursuant to Section 2.2 involves (x) an underwritten offering that was initially requested by any Person(s) (other than a Holder) to whom the Company has granted registration rights which are not inconsistent with the rights granted in,
and do not otherwise conflict with the terms of, this Agreement and the Manager shall advise the Company that, in its view, the number of securities requested to be included in such underwritten offering exceeds the number (the
“Section 2.3(c)(x) Sale Number”) that can be sold in an orderly manner in such underwritten offering within a price range acceptable to the Company or (y) a block trade and the number of securities requested
to be included in such block trade by the Company, the Sponsor Investors or any other Persons exceeds the number that are sold in any such Underwritten Block Trade (the “Section 2.3(c) Block Trade Sale Number”
and, together with the Section 2.3(c)(x) Sale Number, the “Section 2.3(c) Sale Number”), the Company shall use its reasonable best efforts to include in such underwritten offering: 

(i) first, the shares requested to be included in such underwritten offering shall be allocated on a pro rata basis among such Person(s)
requesting the registration and all Holders requesting that Registrable Securities be included in such underwritten offering pursuant to the exercise of piggyback rights pursuant to Section 2.2(a), based on the aggregate number of securities or
Registrable Securities, as applicable, then owned by each of the foregoing requesting inclusion in relation to the aggregate number of securities or Registrable Securities, as applicable, owned by all such Holders and Persons requesting inclusion,
up to the Section 2.3(c) Sale Number; 

  
 19 

 (ii) second, to the extent that the number of Registrable Securities to be included pursuant
to clause (i) of this Section 2.3(c) is less than the Section 2.3(c) Sale Number, the remaining Registrable Securities to be included in such underwritten offering shall be allocated on a pro rata basis among all Persons requesting
that securities be included in such underwritten offering pursuant to the exercise of Additional Piggyback Rights, based on the number of Piggyback Shares then owned by each Person requesting inclusion in relation to the aggregate number of
Piggyback Shares owned by all Persons requesting inclusion, up to the Section 2.3(c) Sale Number; and 
 (iii) third, to the extent
that the number of Registrable Securities to be included pursuant to clauses (i) and (ii) of this Section 2.3(c) is less than the Section 2.3(c) Sale Number, the remaining Registrable Securities to be included in such underwritten
offering shall be allocated to shares the Company proposes to register or sell for its own account, up to the Section 2.3(c) Sale Number. 

(d) If, as a result of the proration provisions set forth in clauses (a), (b) or (c) of this Section 2.3, any Holder shall not be
entitled to include all Registrable Securities in an underwritten offering that such Holder has requested be included, such Holder may elect to withdraw such Holder’s request to include Registrable Securities in the registration to which such
underwritten offering relates or may reduce the number requested to be included; provided, however, that (x) such request must be made in writing prior to the earlier of the execution of the underwriting agreement or the execution
of the custody agreement with respect to such registration and (y) such withdrawal or reduction shall be irrevocable and, after making such withdrawal or reduction, such Holder shall no longer have any right to include Registrable Securities in
the registration as to which such withdrawal or reduction was made to the extent of the Registrable Securities so withdrawn or reduced. 

2.4. Registration Procedures. If and whenever the Company is required by the provisions of this Agreement to effect or cause the
registration of and/or participate in any offering or sale of any Registrable Securities under the Securities Act as provided in this Agreement (or use reasonable best efforts to accomplish the same), the Company shall, as expeditiously as possible:

 (a) prepare and file all filings with the SEC and FINRA required for the consummation of the offering, including preparing and filing
with the SEC a registration statement (including all required exhibits and financial statements) on an appropriate registration form of the SEC for the disposition of such Registrable Securities in accordance with the intended method of disposition
thereof (including, without limitation, a Partner Distribution), which registration form (i) shall be selected by the Company (except as provided for in a Demand Registration Request) and (ii) shall, in the case of a shelf registration, be
available for the sale of the Registrable Securities by the selling Holders thereof and such registration statement shall comply as to form in all material respects with the requirements of the applicable registration form and include all financial
statements required by the SEC to be filed therewith, and the Company shall use its reasonable best efforts to cause such registration statement to become effective and remain continuously effective for such period as any Participating Holder
pursuant to such registration statement shall request (provided, however, that as far in advance as reasonably practicable before filing a registration statement or prospectus or any amendments or supplements thereto, or comparable

  
 20 

 
statements under securities or state “blue sky” Laws of any jurisdiction, or any free writing prospectus related thereto, the Company will furnish to one counsel for the AEA Investors
and one counsel for all other Participating Holder(s) collectively (selected by the holders of a majority of the shares of the Company held by such other Participating Holder(s)) (the “Majority Holders’ Counsel”) and to one
counsel for the Manager, if any, copies of reasonably complete drafts of all such documents proposed to be filed (including all exhibits thereto and each document incorporated by reference therein to the extent then required by the rules and
regulations of the SEC), which documents will be subject to the reasonable review and reasonable comment of such counsel (including any objections to any information pertaining to any Participating Holder and its plan of distribution and otherwise
to the extent necessary, if at all, to complete the filing or maintain the effectiveness thereof), and the Company shall make the changes reasonably requested by such counsel and shall not file any registration statement or amendment thereto, any
prospectus or supplement thereto or any free writing prospectus related thereto to which either (i) the underwriters, if any, or (ii)(a) the AEA Investors, to the extent that no other participating Holder is selling a greater number of
Registrable Securities than the AEA Investors in the offering, or, otherwise, (b) the Majority Participating Holders for the offering, shall reasonably object; provided, however, that, notwithstanding the foregoing, in no event
shall the Company be required to file any document with the SEC which in the view of the Company or its counsel contains an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make any
statement therein not misleading; 
 (b) (i) prepare and file with the SEC such pre- and
post-effective amendments and supplements to such registration statement and the prospectus used in connection therewith and such free writing prospectuses and Exchange Act reports (x) as may be necessary to keep such registration statement
continuously effective for such period as any Participating Holder pursuant to such registration statement shall request, (y) as may be reasonably requested by either (i) the Manager or (ii) (a) the AEA Investors, to the extent that
no other participating Holder is selling a greater number of Registrable Securities than the AEA Investors in the offering, or, otherwise, (b) the Majority Participating Holders for the offering and (z) as may be necessary to comply with
the provisions of the Securities Act with respect to the sale or other disposition of all Registrable Securities covered by such registration statement, and any prospectus so supplemented to be filed pursuant to Rule 424 under the Securities Act, in
accordance with the intended methods of disposition by the seller or sellers thereof set forth in such registration statement and (ii) provide notice to such sellers of Registrable Securities and the Manager, if any, of the Company’s
reasonable determination that a post-effective amendment to a registration statement would be appropriate; 
 (c) furnish, without charge,
to each Participating Holder and each underwriter, if any, of the securities covered by such registration statement such number of copies of such registration statement, each pre- and post-effective amendment
and supplement thereto (in each case including all exhibits), the prospectus included in such registration statement (including each preliminary prospectus and any summary prospectus) and any other prospectus filed under Rule 424 under the
Securities Act, each free writing prospectus utilized in connection therewith, in each case, in all material respects in conformity with the requirements of the Securities Act, and other documents, as such seller and underwriter may reasonably
request in order to facilitate the public sale or other disposition of the Registrable Securities owned by such seller (the Company hereby consenting to the use in accordance with all applicable Laws of each such registration statement (or amendment
or post-effective amendment thereto) and each such prospectus (or preliminary prospectus or supplement thereto) or free writing prospectus by each such Participating Holder and the underwriters, if any, in connection with the offering and sale of
the Registrable Securities covered by such registration statement or prospectus); 

  
 21 

 (d) use its reasonable best efforts to register or qualify the Registrable Securities
covered by such registration statement under such other securities or state “blue sky” Laws of such jurisdictions as any sellers of Registrable Securities or any managing underwriter, if any, shall reasonably request in writing, and do any
and all other acts and things which may be reasonably necessary or advisable to enable such sellers or underwriter, if any, to consummate the disposition of the Registrable Securities in such jurisdictions in accordance with the intended methods of
disposition (including keeping such registration or qualification in effect for so long as such registration statement remains in effect), except that in no event shall the Company be required to qualify to do business as a foreign corporation in
any jurisdiction where it would not, but for the requirements of this paragraph (d), be required to be so qualified, to subject itself to taxation in any such jurisdiction or to consent to general service of process in any such jurisdiction;

 (e) promptly notify each Participating Holder (that is not an individual) and each managing underwriter, if any: (i) when the
registration statement, any pre-effective amendment, the prospectus or any prospectus supplement related thereto, any post-effective amendment to the registration statement or any free writing prospectus has
been filed with the SEC and, with respect to the registration statement or any post-effective amendment, when the same has become effective; (ii) of any request by the SEC or state securities authority for amendments or supplements to the
registration statement or the prospectus related thereto or for additional information; (iii) of the issuance by the SEC of any stop order suspending the effectiveness of the registration statement or the initiation of any proceedings for that
purpose; (iv) of the receipt by the Company of any notification with respect to the suspension of the qualification of any Registrable Securities for sale under the securities or state “blue sky” Laws of any jurisdiction or the
initiation of any proceeding for such purpose; (v) of the existence of any fact of which the Company becomes aware which results in the registration statement or any amendment thereto, the prospectus related thereto or any supplement thereto,
any document incorporated therein by reference, any free writing prospectus or the information conveyed to any purchaser at the time of sale to such purchaser containing an untrue statement of a material fact or omitting to state a material fact
required to be stated therein or necessary to make any statement therein not misleading (which notice shall notify the Participating Holders only of the occurrence of such an event and shall provide no additional information regarding such event to
the extent such information would constitute material non-public information); and (vi) if at any time the representations and warranties contemplated by any underwriting agreement, securities sale
agreement, or other similar agreement, relating to the offering shall cease to be true and correct; and, if the notification relates to an event described in clause (v), unless the Company has declared that a Postponement Period exists, the Company
shall promptly prepare and furnish to each such seller and each underwriter, if any, a reasonable number of copies of a prospectus supplemented or amended so that, as thereafter delivered to the purchasers of such Registrable Securities, such
prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein in the light of the circumstances under which they were made not
misleading; 

  
 22 

 (f) comply (and continue to comply) with all applicable rules and regulations of the SEC
(including, without limitation, maintaining disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f)) in accordance with the Exchange Act), and make generally available to its security holders, as soon as reasonably practicable after the effective date of the registration statement (and in any event
within forty-five (45) days, or ninety (90) days if it is a fiscal year, after the end of such twelve month period described hereafter), an earnings statement (which need not be audited) covering the period of at least twelve
(12) consecutive months beginning with the first day of the Company’s first calendar quarter after the effective date of the registration statement, which earnings statement shall satisfy the provisions of Section 11(a) of the
Securities Act and Rule 158 thereunder; 
 (g) (i) (A) cause all such Registrable Securities covered by such registration statement to
be listed on the principal securities exchange on which similar securities issued by the Company are then listed (if any), if the listing of such Registrable Securities is then permitted under the rules of such exchange, or (B) if no similar
securities are then so listed, to cause all such Registrable Securities to be listed on a national securities exchange and, without limiting the generality of the foregoing, take all actions that may be required by the Company as the issuer of such
Registrable Securities in order to facilitate the managing underwriter’s arranging for the registration of at least two market makers as such with respect to such shares with FINRA, and (ii) comply (and continue to comply) with the
requirements of any self-regulatory organization applicable to the Company, including without limitation all corporate governance requirements; 

(h) cause its senior management, officers, employees and independent public accountants to participate in, make themselves available, supply
such information as may be reasonably requested and to otherwise facilitate and cooperate with the preparation of the registration statement and prospectus and any amendments or supplements thereto (including participating in meetings, drafting
sessions, due diligence sessions and rating agency presentations) taking into account the Company’s reasonable business needs; 
 (i)
provide and cause to be maintained a transfer agent and registrar for all such Registrable Securities covered by such registration statement not later than the effective date of such registration statement and, in the case of any secondary equity
offering, provide and enter into any reasonable agreements with a custodian for the Registrable Securities; 
 (j) enter into such customary
agreements (including, if applicable, an underwriting agreement) and take such other actions as either (i) the underwriters or (ii)(a) the AEA Investors, to the extent that no other participating Holder is selling a greater number of
Registrable Securities than the AEA Investors in the offering, or, otherwise, (b) the Majority Participating Holders for the offering, shall reasonably request in order to expedite or facilitate the disposition of such Registrable Securities
(it being understood that the Holders of the Registrable Securities which are to be distributed by any underwriters shall be parties to any such underwriting agreement and may, at their option, require that the Company make to and for the benefit of
such Holders the representations, warranties and covenants of the Company which are being made to and for the benefit of such underwriters); 

  
 23 

 (k) use its reasonable best efforts to (i) obtain opinions from the Company’s
counsel, including without limitation local and/or regulatory counsel, and a “cold comfort” letter, updates thereof and consents from the independent public accountants who have certified the financial statements of the Company (and/or any
other financial statements) included or incorporated by reference in such registration statement, in each case, in customary form and covering such matters as are customarily covered by such opinions and “cold comfort” letters (including,
in the case of such “cold comfort” letter, events subsequent to the date of such financial statements) delivered to underwriters in underwritten public offerings, which opinions and letters shall be dated the dates such opinions and
“cold comfort” letters are customarily dated and, in the case of an underwritten offering, addressed to the underwriters and otherwise reasonably satisfactory to (a) the underwriters, if any, and to (b)(1) the AEA Investors, to the
extent that no other participating Holder is selling a greater number of Registrable Securities than the AEA Investors in the offering, or, otherwise, (2) the Majority Participating Holders for the offering, and (ii) furnish to each
Participating Holder upon its request and to each underwriter, if any, a copy of such opinions and letters addressed to such underwriter and each Participating Holder to the extent permitted by the Company’s independent public accountants; 

(l) deliver promptly to counsel for the AEA Investors and Majority Holders’ Counsel and to each managing underwriter, if any, copies of
all correspondence between the SEC and the Company, its counsel or auditors and all memoranda relating to discussions with the SEC or its staff with respect to the registration statement, and, upon receipt of such confidentiality agreements as the
Company may reasonably request, make reasonably available for inspection by counsel for the AEA Investors, by Majority Holders’ Counsel, by counsel for any underwriter participating in any disposition to be effected pursuant to such
registration statement and by any attorney, accountant or other agent retained by (i) any such underwriter, (ii) the AEA Investors or (iii) the Majority Participating Holders, all pertinent financial and other records, pertinent
corporate documents and properties of the Company, and cause all of the Company’s officers, directors and employees to supply all information reasonably requested by any such counsel for the AEA Investors, Majority Holders’ Counsel,
counsel for an underwriter, attorney, accountant or agent in connection with such registration statement; 
 (m) use its reasonable best
efforts to prevent the issuance or obtain the withdrawal of any order suspending the effectiveness of the registration statement, or the lifting of any suspension of the qualification of any of the Registrable Securities for sale in any
jurisdiction, in each case, as promptly as reasonably practicable; 
 (n) provide a CUSIP number for all Registrable Securities, not later
than the effective date of the registration statement and, if applicable, provide the applicable transfer agent with printed certificates for the Registrable Securities which are in a form eligible for deposit with The Depository Trust Company; 

(o) use its reasonable best efforts to make available its senior management, employees and personnel for participation in “road
shows” and other marketing efforts and otherwise provide reasonable assistance to the underwriters (taking into account the Company’s reasonable business needs and the requirements of the marketing process) in the marketing of Registrable
Securities in any underwritten offering; 

  
 24 

 (p) promptly prior to the filing of any document which is to be incorporated by reference
into the registration statement or the prospectus (after the initial filing of such registration statement), and prior to the filing or use of any free writing prospectus, provide copies of such document to counsel for the AEA Investors, Majority
Holders’ Counsel and to each managing underwriter, if any, and make the Company’s representatives reasonably available for discussion of such document and make such changes in such document concerning the Participating Holders prior to the
filing thereof as counsel for the AEA Investors, Majority Holders’ Counsel or counsel for the underwriters may reasonably request (provided, however, that, notwithstanding the foregoing, in no event shall the Company be required
to file any document with the SEC which in the view of the Company or its counsel contains an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make any statement therein not
misleading); 
 (q) furnish to counsel for the AEA Investors upon its request, Majority Holders’ Counsel upon its request and to each
managing underwriter, upon request, in each case without charge, at least one conformed copy of the registration statement and any post-effective amendments or supplements thereto, including financial statements and schedules, all documents
incorporated therein by reference, the prospectus contained in such registration statement (including each preliminary prospectus and any summary prospectus), any other prospectus and prospectus supplement filed under Rule 424 under the Securities
Act and all exhibits (including those incorporated by reference) and any free writing prospectus utilized in connection therewith; 
 (r)
cooperate with the Participating Holders and the managing underwriter, if any, to facilitate the timely preparation and delivery of certificates not bearing any restrictive legends representing the Registrable Securities to be sold, and cause such
Registrable Securities to be issued in such denominations and registered in such names in accordance with the underwriting agreement at least two (2) Business Days prior to any sale of Registrable Securities to the underwriters or, if not an
underwritten offering, in accordance with the instructions of the Participating Holders at least two (2) Business Days prior to any sale of Registrable Securities and instruct any transfer agent and registrar of Registrable Securities to
release any stop transfer orders in respect thereof (and, in the case of Registrable Securities registered on a Shelf Registration Statement, at the request of any Holder, prepare and deliver certificates representing such Registrable Securities not
bearing any restrictive legends and deliver or cause to be delivered an opinion or instructions to the transfer agent in order to allow such Registrable Securities to be sold from time to time); 

(s) include in any prospectus or prospectus supplement if requested by any managing underwriter updated financial or business information for
the Company’s most recent period or current quarterly period (including estimated results or ranges of results) if required for purposes of marketing the offering in the view of the managing underwriter; 

(t) take no direct or indirect action prohibited by Regulation M under the Exchange Act; provided, however, that to the extent
that any prohibition is applicable to the Company, the Company will use its reasonable best efforts to make any such prohibition inapplicable; 

  
 25 

 (u) use its reasonable best efforts to cause the Registrable Securities covered by the
applicable registration statement to be registered with or approved by such other governmental agencies or authorities as may be necessary to enable the Participating Holders or the underwriters, if any, to consummate the disposition of such
Registrable Securities in accordance with the intended methods thereof; 
 (v) take all such other commercially reasonable actions as are
necessary or advisable in order to expedite or facilitate the disposition of such Registrable Securities; 
 (w) take all reasonable action
to ensure that any free writing prospectus utilized in connection with any registration covered by Section 2.1 or 2.2 complies in all material respects with the Securities Act, is filed in accordance with the Securities Act to the extent
required thereby, is retained in accordance with the Securities Act to the extent required thereby, will not conflict with a related prospectus, prospectus supplement and related documents and, when taken together with the related prospectus,
prospectus supplement and related documents, will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not
misleading; 
 (x) in connection with any underwritten offering, if at any time the information conveyed to a purchaser at the time of sale
includes any untrue statement of a material fact or omits to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, promptly file with the SEC such
amendments or supplements to such information as may be necessary so that the statements as so amended or supplemented will not, in the light of the circumstances, be misleading; 

(y) to the extent required by the rules and regulations of FINRA, retain a Qualified Independent Underwriter acceptable to the managing
underwriter; and 
 (z) use reasonable best efforts to cooperate with the managing underwriters, Participating Holders, any indemnitee of
the Company and their respective counsel in connection with the preparation and filing of any applications, notices, registrations and responses to requests for additional information with FINRA, the New York Stock Exchange, Nasdaq, or any other
national securities exchange on which the shares of Common Stock are or are to be listed. 
 To the extent the Company is a WKSI at the time
any Demand Registration Request is submitted to the Company, the Company shall file an automatic shelf registration statement which covers those Registrable Securities which are requested to be registered. The Company shall use its reasonable best
efforts to remain a WKSI (and not become an ineligible issuer (as defined in Rule 405 under the Securities Act)) during the period during which such automatic shelf registration statement is required to remain effective. If the Company does not pay
the filing fee covering the Registrable Securities at the time the automatic shelf registration statement is filed, the Company agrees to pay such fee at such time or times as the Registrable Securities are to be sold in compliance with the SEC
rules. If the automatic shelf registration statement has been outstanding for at least three (3) years, at or prior to the end of the third year the Company shall promptly upon request refile a new automatic shelf registration statement
covering the Registrable Securities that remain outstanding. If at any time when the Company is required to re-evaluate its WKSI status the Company determines that it is not a WKSI, the Company shall use its
reasonable best efforts to refile the shelf registration statement on Form S-3 and, if such form is not available, Form S-1 and keep such registration statement
effective during the period during which such registration statement is required to be kept effective. 

  
 26 

 If the Company files any Shelf Registration Statement for the benefit of the holders of any
of its securities other than the Holders, and the Holders do not request that their Registrable Securities be included in such Shelf Registration Statement, the Company agrees that it shall include in such registration statement such disclosures as
may be required by Rule 430B under the Securities Act (referring to the unnamed selling security holders in a generic manner by identifying the initial offering of the securities to the Holders) in order to ensure that the Holders may be added to
such Shelf Registration Statement at a later time through the filing of a prospectus supplement rather than a post-effective amendment. 

The Company may require that each Participating Holder as to which any registration is being effected (i) furnish the Company such
information regarding such seller and the distribution of such securities as the Company may from time to time reasonably request, provided that such information is necessary for the Company to consummate such registration and shall be used only in
connection with such registration and (ii) provide any underwriters participating in the distribution of such securities such information as the underwriters may request and execute and deliver any agreements, certificates or other documents as
the underwriters may request. 
 Each Holder of Registrable Securities agrees that upon receipt of any notice from the Company of the
happening of any event of the kind described in clause (v) of paragraph (e) of this Section 2.4, such Holder will discontinue such Holder’s disposition of Registrable Securities pursuant to the registration statement covering
such Registrable Securities until such Holder’s receipt of the copies of the supplemented or amended prospectus contemplated by paragraph (e) of this Section 2.4 and, if so directed by the Company, will deliver to the Company (at the
Company’s expense) all copies, other than permanent file copies, then in such Holder’s possession of the prospectus covering such Registrable Securities that was in effect at the time of receipt of such notice. In the event the Company
shall give any such notice, the applicable period mentioned in paragraph (b) of this Section 2.4 shall be extended by the number of days during such period from and including the date of the giving of such notice to and including the date
when each Participating Holder covered by such registration statement shall have received the copies of the supplemented or amended prospectus contemplated by paragraph (e) of this Section 2.4. The period(s) during which the Holders are
required to discontinue disposition of securities pursuant to this paragraph shall not exceed forty-five (45) days with respect to any one such period, or ninety (90) days during any period of three hundred sixty (360) days with
respect to multiple such periods. 
 The Company agrees not to file or make any amendment to any registration statement with respect to any
Registrable Securities, any prospectus, or any amendment of or supplement to the prospectus, or any free writing prospectus, that refers to any Sponsor Investor or Management Investor (or any of their respective Affiliates) covered thereby by name,
or otherwise identifies any Sponsor Investor or Management Investor (or any of their respective Affiliates), without the consent of the applicable Sponsor Investor or Management Investor, as the case may be, such consent not to be unreasonably
withheld or delayed, unless such disclosure is required by Law, in which case the Company shall provide written notice to such Sponsor Investor 

  
 27 

 
or Management Investor, as applicable, no less than five (5) Business Days prior to the filing. If any such registration statement or comparable statement under state “blue sky”
Laws refers to any Holder (or any of its Affiliates) by name or otherwise as the Holder of any securities of the Company, then such Holder shall have the right to require the insertion therein of language, in form and substance reasonably
satisfactory to such Holder and the Company, to the effect that the holding by such Holder of such securities is not to be construed as a recommendation by such Holder of the investment quality of the Company’s securities covered thereby and
that such holding does not imply that such Holder will assist in meeting any future financial requirements of the Company. 
 To the extent
that any Sponsor Investor or Management Investor is or may be deemed to be an “underwriter” of Registrable Securities pursuant to any SEC comments or policies, the Company agrees that (1) the indemnification and contribution
provisions contained in Section 2.9 shall be applicable to the benefit of the Sponsor Investors and Management Investors, as applicable, in their role as an underwriter or deemed underwriter in addition to their capacity as a Holder and
(2) the Sponsor Investors and Management Investors, as applicable, shall be entitled to conduct the due diligence which they would normally conduct in connection with an offering of securities registered under the Securities Act, including
without limitation receipt of customary opinions and comfort letters addressed to the such Sponsor Investors and Management Investors, as applicable. 

2.5. Registration Expenses. 

(a) The Company shall pay all Expenses with respect to any registration or offering of Registrable Securities pursuant to Section 2,
whether or not a registration statement becomes effective or the offering is consummated. 
 (b) Notwithstanding the foregoing, (x) the
provisions of this Section 2.5 shall be deemed amended to the extent necessary to cause these expense provisions to comply with state “blue sky” Laws of each state in which the offering is made and (y) in connection with any
underwritten offering hereunder, each Participating Holder shall pay all underwriting discounts and commissions and any transfer taxes, if any, attributable to the sale of such Registrable Securities, pro rata with respect to payments of discounts
and commissions in accordance with the number of shares sold in the offering by such Participating Holder. 
 2.6. Certain Limitations on
Registration Rights. In the case of any registration under Section 2.1 involving an underwritten offering, or, in the case of a registration under Section 2.2, if the Company has determined to enter into an underwriting agreement in
connection therewith, all securities to be included in such underwritten offering shall be subject to such underwriting agreement and no Person may participate in such underwritten offering unless such Person (i) agrees to sell such
Person’s securities on the basis provided therein and completes and executes all reasonable questionnaires, and other documents (including custody agreements and powers of attorney, if any) which must be executed in connection therewith;
provided, however, that all such documents shall be consistent with the provisions hereof and (ii) provides such other information to the Company or the underwriter as may be necessary to register such Person’s securities.

  
 28 

 2.7. Limitations on Sale or Distribution of Other Securities. 

(a) Each Holder agrees (whether or not such Holder can participate in any such offering), (i) to the extent requested by a managing
underwriter, if any, of any underwritten public offering pursuant to a registration or offering effected pursuant to Section 2.1 (including any Shelf Underwriting or Underwritten Block Trade pursuant to Section 2.1(e)), or of the
Company’s IPO, not to sell, transfer or otherwise dispose of, including any sale pursuant to Rule 144, any Common Stock or Common Stock Equivalent (other than as part of such underwritten public offering) during the time period reasonably
requested by the managing underwriter, not to exceed ninety (90) days from the pricing date of such offering or such shorter period as the managing underwriter shall agree to (other than in the case of the IPO, which time period shall be one
hundred eighty (180) days from the pricing date of such offering) and (ii) to the extent requested by a managing underwriter of any underwritten public offering effected by the Company for its own account (including, without limitation,
any offering in which one or more Holders is selling Common Stock pursuant to the exercise of piggyback rights under Section 2.2 hereof), or of the Company’s IPO, not to sell, transfer or otherwise dispose of, including any sale pursuant
to Rule 144, any Common Stock or Common Stock Equivalent (other than as part of such underwritten public offering) during the time period reasonably requested by the managing underwriter, which period shall not exceed ninety (90) days from
the pricing date of such offering or such shorter period as the managing underwriter shall agree to (other than in the case of the IPO, which time period shall be one hundred eighty (180) days from the pricing date of such offering). Each
Holder agrees to execute and deliver customary lock-up agreements for the benefit of the underwriters with such form and substance as the managing underwriter shall reasonably determine. The Company agrees to
use its reasonable best efforts to cause each holder of Common Stock or Common Stock Equivalents, purchased or otherwise acquired from the Company (other than in a public offering) at any time to agree, and shall use its reasonable best efforts to
cause each of its officers, directors and beneficial holders of 5% or more of the Company’s outstanding Common Stock to agree, not to sell, transfer or otherwise dispose of, including any sale pursuant to Rule 144, any Common Stock or Common
Stock Equivalent (other than as part of such underwritten public offering) during the period referred to in the first sentence of this clause (a). 

(b) The Company hereby agrees that, in connection with an offering pursuant to Section 2.1 (including any Shelf Underwriting or
Underwritten Block Trade pursuant to Section 2.1(e)), Section 2.2 or the Company’s IPO, the Company shall not sell, transfer, or otherwise dispose of, any Common Stock or Common Stock Equivalent (other than as part of such
underwritten public offering, a registration on Form S-4 or Form S-8 or any successor or similar form which is (x) then in effect or (y) shall become effective
upon the conversion, exchange or exercise of any then outstanding Common Stock Equivalent), until a period of ninety (90) days (or such shorter period to which the managing underwriter shall agree, but one hundred eighty (180) days in the
case of the IPO) shall have elapsed from the pricing date of such offering; and the Company shall so provide in any registration rights agreements hereafter entered into with respect to any of its securities. 

  
 29 

 (c) Notwithstanding anything contained in this Agreement to the contrary, each of the
Minority Investors agrees that it shall not sell, transfer or otherwise dispose of any Common Stock or Common Stock Equivalent, effect any Partner Distribution or request any Demand Registration (including any Shelf Underwriting or Underwritten
Block Trade) for a period of two (2) years following the pricing date of the Company’s IPO (the “Restricted Period”), except: (i) for sales, transfers or distributions pursuant to a registered offering in accordance
with the exercise of registration rights set forth in Sections 2.1(a)(i), 2.1(e) or 2.2(a), as applicable; (ii) if consented to in writing by the Board in its sole discretion, which consent may be provided on an individual basis with respect to
any particular Holder; (iii) for sales, transfers or distributions to a Permitted Affiliate Transferee; or (iv) for sales or transfers by the Management Investors, after the one-year anniversary of
the pricing date for the Company’s IPO, (a) pursuant to a written plan, contract, instruction or arrangement that meets the requirements of Rule 10b5-1(c) under the Exchange Act and (b) in
compliance with any applicable volume and manner of sale requirements of Rule 144. 
 2.8. No Required Sale. Nothing in this
Agreement shall be deemed to create an independent obligation on the part of any Holder to sell any Registrable Securities pursuant to any effective registration statement. A Holder is not required to include any of its Registrable Securities in any
registration statement, is not required to sell any of its Registrable Securities which are included in any effective registration statement, and, subject to Section 2.7, may sell any of its Registrable Securities in any manner in compliance
with applicable Law (including pursuant to Rule 144) even if such shares are already included on an effective registration statement. 

2.9. Indemnification. 

(a) In the event of any registration or offer and sale of any securities of the Company under the Securities Act pursuant to this
Section 2, the Company will (without limitation as to time), and hereby agrees to, and hereby does, indemnify and hold harmless, to the fullest extent permitted by Law, each Participating Holder, its directors, officers, fiduciaries, employees,
stockholders, members, general and limited partners, agents, affiliates, consultants, representatives, successors and assigns (and the directors, officers, fiduciaries, employees, stockholders, members, general and limited partners, agents,
affiliates, consultants, representatives, successors and assigns thereof), each other Person who participates as a seller (and its directors, officers, fiduciaries, employees, stockholders, members, general and limited partners, agents, affiliates,
consultants, representatives, successors and assigns), underwriter or Qualified Independent Underwriter, if any, in the offering or sale of such securities, each officer, director, employee, stockholder, fiduciary, managing director, agent,
affiliate, consultant, representative, successor, assign or partner of such underwriter or Qualified Independent Underwriter, and each other Person, if any, who controls (within the meaning of Section 15 of the Securities Act or Section 20
of the Exchange Act) such seller or any such underwriter or Qualified Independent Underwriter and each director, officer, employee, stockholder, fiduciary, managing director, agent, affiliate, consultant, representative, successor, assign or partner
of such controlling Person, from and against any and all losses, claims, damages, penalties, judgments, suits, or liabilities, joint or several, actions or proceedings (whether commenced or threatened) and expenses (including reasonable fees of
counsel and any amounts paid in any settlement effected with the Company’s consent, which consent shall not be unreasonably withheld or delayed) to which each such indemnified party may become subject under the Securities Act or otherwise in
respect thereof (collectively, “Claims”), insofar as such Claims arise out of, are based upon, relate to or are in connection with (i) any untrue statement or alleged untrue statement of a material fact contained in any
registration statement under which such securities were registered under the Securities Act or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not
misleading, (ii) any untrue statement or alleged untrue 

  
 30 

 
statement of a material fact contained in any preliminary, final or summary prospectus or any amendment or supplement thereto, together with the documents incorporated by reference therein, or
any free writing prospectus utilized in connection therewith, or the omission or alleged omission to state therein a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not
misleading, (iii) any untrue statement or alleged untrue statement of a material fact in the information conveyed by the Company or any underwriter to any purchaser at the time of the sale to such purchaser, or the omission or alleged omission
to state therein a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, or (iv) any violation by the Company of any federal, state or common Law rule or
regulation applicable to the Company and relating to any action required of or inaction by the Company in connection with any such offering of Registrable Securities, and the Company will reimburse any such indemnified party for any legal or other
expenses reasonably incurred by such indemnified party in connection with investigating or defending any such Claim as such expenses are incurred; provided, however, that the Company shall not be liable to any such indemnified party in
any such case to the extent such Claim arises out of or is based upon any untrue statement or alleged untrue statement of a material fact or omission or alleged omission of a material fact made in such registration statement or amendment thereof or
supplement thereto or in any such prospectus or any preliminary, final or summary prospectus or free writing prospectus in reliance upon and in strict conformity with written information furnished to the Company or its representatives by or on
behalf of such indemnified party specifically for use therein. Such indemnity and reimbursement of expenses shall remain in full force and effect regardless of any investigation made by or on behalf of such indemnified party and shall survive the
transfer of such securities by such seller. 
 (b) Each Participating Holder (and, if the Company requires as a condition to including any
Registrable Securities in any registration statement filed in accordance with Section 2.1 or 2.2, any underwriter and Qualified Independent Underwriter, if any) shall, severally and not jointly, indemnify and hold harmless (in the same manner
and to the same extent as set forth in paragraph (a) of this Section 2.9) to the extent permitted by Law, the Company, its officers who signed the applicable registration statement and its directors, each Person controlling the Company
within the meaning of the Securities Act and all other prospective sellers and their directors, officers, stockholders, fiduciaries, managing directors, agents, affiliates, consultants, representatives, successors, assigns or general and limited
partners and respective controlling Persons with respect to any untrue statement or alleged untrue statement of any material fact in, or omission or alleged omission of any material fact from, such registration statement, any preliminary, final or
summary prospectus contained therein, or any amendment or supplement thereto, or any free writing prospectus utilized in connection therewith, if such statement or alleged statement or omission or alleged omission was made in reliance upon and in
strict conformity with written information furnished to the Company or its representatives by or on behalf of such Participating Holder or underwriter or Qualified Independent Underwriter, if any, specifically for use therein, and each such
Participating Holder, underwriter or Qualified Independent Underwriter, if any, shall reimburse such indemnified party for any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any
such Claim as such expenses are incurred; provided, however, that the aggregate amount which any such Participating Holder shall be required to pay pursuant to this Section 2.9 (including pursuant to indemnity, contribution or
otherwise) shall in no case be greater than the amount of the net proceeds received by such Participating Holder upon the sale of the Registrable Securities 

  
 31 

 
pursuant to the registration statement giving rise to such Claim; provided, further, that such Participating Holder shall not be liable in any such case to the extent that prior to
the filing of any such registration statement or prospectus or amendment thereof or supplement thereto, or any free writing prospectus utilized in connection therewith, such Participating Holder has furnished in writing to the Company information
expressly for use in such registration statement or prospectus or any amendment thereof or supplement thereto or free writing prospectus which corrected or made not misleading information previously furnished to the Company. The Company and each
Participating Holder hereby acknowledge and agree that, unless otherwise expressly agreed to in writing by such Participating Holders to the contrary, for all purposes of this Agreement, the only information furnished or to be furnished to the
Company for use in any such registration statement, preliminary, final or summary prospectus or amendment or supplement thereto, or any free writing prospectus, are statements specifically relating to (i) the beneficial ownership of shares of
Common Stock by such Participating Holder and its Affiliates as disclosed in the section of such document entitled “Selling Stockholders” or “Principal and Selling Stockholders” or other documents thereof and (ii) the name,
address and other information with respect to such Participating Holder that appears in the table and corresponding footnotes describing such Participating Holder in the section of such document entitled “Selling Stockholders” or
“Principal and Selling Stockholders” or other documents thereof. If any additional information about such Holder or the plan of distribution (other than for an underwritten offering) is required by Law to be disclosed in any such document,
then such Holder shall not unreasonably withhold its agreement referred to in the immediately preceding sentence. Such indemnity and reimbursement of expenses shall remain in full force and effect regardless of any investigation made by or on behalf
of such indemnified party and shall survive the transfer of such securities by such Holder. 
 (c) Indemnification similar to that specified
in the preceding paragraphs (a) and (b) of this Section 2.9 (with appropriate modifications) shall be given by the Company and each Participating Holder with respect to any required registration or other qualification of securities under
any applicable securities and state “blue sky” Laws. 
 (d) Any Person entitled to indemnification under this Agreement shall
notify promptly the indemnifying party in writing of the commencement of any action or proceeding with respect to which a claim for indemnification may be made pursuant to this Section 2.9, but the failure of any indemnified party to provide
such notice shall not relieve the indemnifying party of its obligations under the preceding paragraphs of this Section 2.9, except to the extent the indemnifying party is materially and actually prejudiced thereby and shall not relieve the
indemnifying party from any liability which it may have to any indemnified party otherwise than under this Section 2. In case any action or proceeding is brought against an indemnified party and such indemnified party shall have notified the
indemnifying party of the commencement thereof (as required above), the indemnifying party shall be entitled to participate therein and, unless in the reasonable opinion of outside counsel to the indemnified party a conflict of interest between such
indemnified and indemnifying parties may exist in respect of such Claim, to assume the defense thereof jointly with any other indemnifying party similarly notified, to the extent that it chooses, with counsel reasonably satisfactory to such
indemnified party, and after notice from the indemnifying party to such indemnified party that it so chooses, the indemnifying party shall not be liable to such indemnified party for any legal or other expenses subsequently incurred by such
indemnified party in connection with the defense thereof other than reasonable costs of investigation; provided, however, that: (i) if the indemnifying party fails to take reasonable steps

  
 32 

 
necessary to defend diligently the action or proceeding within twenty (20) days after receiving notice from such indemnified party that the indemnified party believes it has failed to do so;
or (ii) if such indemnified party who is a defendant in any action or proceeding which is also brought against the indemnifying party reasonably shall have concluded that there may be one or more legal or equitable defenses available to such
indemnified party which are not available to the indemnifying party or which may conflict with or be different from those available to another indemnified party with respect to such Claim; or (iii) if representation of both parties by the same
counsel is otherwise inappropriate under applicable standards of professional conduct, then, in any such case, the indemnified party shall have the right to assume or continue its own defense as set forth above (but with no more than one counsel for
all indemnified parties in each jurisdiction, except to the extent any indemnified party or parties reasonably shall have made a conclusion described in clause (ii) or (iii) above) and the indemnifying party shall be liable for any expenses
therefor. No indemnifying party shall, without the written consent of the indemnified party, effect the settlement or compromise of, or consent to the entry of any judgment with respect to, any pending or threatened action or claim in respect of
which indemnification or contribution may be sought hereunder (whether or not the indemnified party is an actual or potential party to such action or claim) unless such settlement, compromise or judgment (A) includes an unconditional release of
the indemnified party from all liability arising out of such action or claim and (B) does not include a statement as to or an admission of fault, culpability or a failure to act, by or on behalf of any indemnified party. 

(e) If for any reason the foregoing indemnity is unavailable, unenforceable or is insufficient to hold harmless an indemnified party under
Sections 2.9(a), (b) or (c), then each applicable indemnifying party shall contribute to the amount paid or payable to such indemnified party as a result of any Claim in such proportion as is appropriate to reflect the relative fault of the
indemnifying party, on the one hand, and the indemnified party, on the other hand, with respect to such Claim. The relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material
fact or the omission or alleged omission to state a material fact relates to information supplied by the indemnifying party or the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct
or prevent such untrue statement or omission. If, however, the allocation provided in the second preceding sentence is not permitted by applicable Law, then each indemnifying party shall contribute to the amount paid or payable by such indemnified
party in such proportion as is appropriate to reflect not only such relative faults but also the relative benefits of the indemnifying party and the indemnified party as well as any other relevant equitable considerations. The parties hereto agree
that it would not be just and equitable if any contribution pursuant to this Section 2.9(e) were to be determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred
to in the preceding sentences of this Section 2.9(e). The amount paid or payable in respect of any Claim shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or
defending any such Claim. No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation.
Notwithstanding anything in this Section 2.9(e) to the contrary, no indemnifying party (other than the Company) shall be required pursuant to this Section 2.9(e) to contribute any amount greater than the amount of the net proceeds received
by such indemnifying party from the sale of Registrable Securities pursuant to the registration statement giving rise to such Claim, less the amount of any indemnification payment made by such indemnifying party pursuant to Sections 2.9(b) and (c).
In addition, no Holder of Registrable Securities or any Affiliate thereof shall be required to pay any amount under this Section 2.9(e) unless such Person or entity would have been required to pay an amount pursuant to Section 2.9(b) if it
had been applicable in accordance with its terms. 

  
 33 

 (f) The indemnity and contribution agreements contained herein shall be in addition to any
other rights to indemnification or contribution which any indemnified party may have pursuant to Law or contract and shall remain operative and in full force and effect regardless of any investigation made or omitted by or on behalf of any
indemnified party and shall survive the transfer of the Registrable Securities by any such party. 
 (g) The indemnification and
contribution required by this Section 2.9 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received or expense, loss, damage or liability is incurred. 

2.10. Limitations on Registration of Other Securities; Representation. From and after the date of this Agreement, the Company shall
not, without the prior written consent of the AEA Investors, enter into any agreement with any holder or prospective holder of any securities of the Company giving such holder or prospective holder any registration rights the terms of which are
(a) more favorable taken as a whole than the registration rights granted to the Holders hereunder unless the Company shall also give such rights to such Holders or (b) on parity with the registration rights granted to the Holders
hereunder; provided, however, the prior written consent of any Initial Investor or any of its Permitted Affiliate Transferees will be required prior to the Company entering into any such agreement with any such holder or prospective
holder of any securities of the Company to the extent such agreement disproportionately adversely affects any such Initial Investor or any of its Permitted Affiliate Transferee relative to the other Holders. 

2.11. No Inconsistent Agreements. The Company shall not hereafter enter into any agreement with respect to its securities that is
inconsistent in any material respects with the rights granted to the Holders in this Agreement. 
 Section 3. Underwritten
Offerings. 
 3.1. Requested Underwritten Offerings. If requested by the underwriters for any underwritten offering pursuant to a
registration requested under Section 2.1, the Company shall enter into a customary underwriting agreement with the underwriters. Such underwriting agreement shall (i) be satisfactory in form and substance to (1) the AEA Investors, to
the extent that no other participating Holder is selling a greater number of Registrable Securities than the AEA Investors in such underwritten offering, or, otherwise, (2) the Majority Participating Holders for such underwritten offering;
(ii) contain terms not inconsistent with the provisions of this Agreement in any material respect, unless otherwise agreed by (a) (1) the AEA Investors, to the extent that no other participating Holder is selling a greater number of
Registrable Securities than the AEA Investors in such underwritten offering, or, otherwise, (2) the Majority Participating Holders for such underwritten offering and (b) the underwriters for such underwritten offering; and
(iii) contain such representations and warranties by, and such other agreements on the part of, the Company and such other terms as are generally prevailing in agreements of that type, including, without limitation, indemnities and contribution
agreements. Any Participating Holder shall be a 

  
 34 

 
party to such underwriting agreement and may, at its option, require (unless otherwise agreed by (i) the underwriters and (ii)(a)the AEA Investors, to the extent that no other participating
Holder is selling a greater number of Registrable Securities than the AEA Investors in such underwritten offering, or, otherwise, (b) the Majority Participating Holders for such offering) that any or all of the representations and warranties
by, and the other agreements on the part of, the Company to and for the benefit of such underwriters shall also be made to and for the benefit of such Participating Holder; provided, however, that the Company shall not be required to
make any representations or warranties with respect to written information specifically provided by a Participating Holder for inclusion in any registration statement or prospectus. Unless otherwise agreed by (i) the underwriters and (ii)(a)
the AEA Investors, to the extent that no other participating Holder is selling a greater number of Registrable Securities than the AEA Investors in such underwritten offering, or, otherwise, (b) the Majority Participating Holders for such
underwritten offering, each Participating Holder shall not be required to make any representations or warranties to or agreements with the Company or the underwriters other than representations, warranties or agreements regarding such Participating
Holder, its ownership of and title to the Registrable Securities, any written information specifically provided by such Participating Holder for inclusion in the registration statement and its intended method of distribution; and any liability of
such Participating Holder to any underwriter or other Person under such underwriting agreement for indemnity, contribution or otherwise shall in no case be greater than the amount of the net proceeds received by such Participating Holder upon the
sale of Registrable Securities pursuant to such underwriting agreement and in no event shall relate to anything other than information about such Holder specifically provided by such Holder for use in any registration statement or prospectus. 

3.2. Piggyback Underwritten Offerings. In the case of a registration pursuant to Section 2.2, if the Company shall have determined
to enter into an underwriting agreement in connection therewith, all of the Participating Holders’ Registrable Securities to be included in such registration shall be subject to such underwriting agreement. Any Participating Holder may, at its
option, require (unless otherwise agreed by (i) the underwriters and (ii)(a) the AEA Investors, to the extent that no other participating Holder is selling a greater number of Registrable Securities than the AEA Investors in such underwritten
offering, or, otherwise, (b) the Majority Participating Holders for such underwritten offering) that any or all of the representations and warranties by, and the other agreements on the part of, the Company to and for the benefit of such
underwriters shall also be made to and for the benefit of such Participating Holder and that any or all of the conditions precedent to the obligations of such underwriters under such underwriting agreement be conditions precedent to the obligations
of such Participating Holder; provided, however. that the Company shall not be required to make any representations or warranties with respect to written information specifically provided by a Participating Holder for inclusion in the
registration statement. Unless otherwise agreed by (i) the underwriters and (ii)(a) the AEA Investors, to the extent that no other participating Holder is selling a greater number of Registrable Securities than the AEA Investors in such
underwritten offering, or, otherwise, (b) the Majority Participating Holders for such offering, each Participating Holder shall not be required to make any representations or warranties to or agreements with the Company or the underwriters
other than representations, warranties or agreements regarding such Participating Holder, its ownership of and title to the Registrable Securities, any written information specifically provided by such Participating Holder for inclusion in any
registration statement or prospectus and its intended method of distribution; and any liability of such Participating Holder to any underwriter or other Person under such underwriting agreement shall in no case be greater than the amount of the net
proceeds received by such Participating Holder upon the sale of Registrable Securities pursuant to such underwriting agreement and in no event shall relate to anything other than information about such Holder specifically provided by such Holder for
use in any registration statement or prospectus. 

  
 35 

 Section 4. General. 

4.1. Adjustments Affecting Registrable Securities. The Company agrees that it shall not effect or permit to occur any combination or
subdivision of shares of Common Stock which would adversely affect the ability of any Holder of any Registrable Securities to include such Registrable Securities in any registration or offering contemplated by this Agreement or the marketability of
such Registrable Securities in any such registration or offering. Subject to the foregoing, the Company agrees that it will take all reasonable steps necessary to effect a combination or subdivision of shares of Common Stock if in the reasonable
judgment of (a)(i) the AEA Investors, to the extent that no other participating Holder is selling a greater number of Registrable Securities than the AEA Investors in the offering in respect of such Demand Registration Request, or, otherwise,
(ii) the Majority Participating Holders for the offering in respect of such Demand Registration Request or (b) the managing underwriter for the offering in respect of such Demand Registration Request, such combination or subdivision would
enhance the marketability of the Registrable Securities; provided, that, the consent of any Minority Investor shall be required prior to any such combination or subdivision to the extent it disproportionately adversely affects such Minority Investor
relative to the other Holders. Each Holder agrees to vote all of its shares of capital stock in a manner, and to take all other actions reasonably necessary, to permit the Company to carry out the intent of the preceding sentence including, without
limitation, voting in favor of an amendment to the Company’s organizational documents in order to increase the number of authorized shares of capital stock of the Company. In any event, the provisions of this Agreement shall apply, to the full
extent set forth herein with respect to the Registrable Securities, to any and all shares of capital stock of the Company, any successor or assign of the Company (whether by merger, share exchange, consolidation, sale of assets or otherwise) or any
Subsidiary or parent company of the Company which may be issued in respect of, in exchange for or in substitution of, Registrable Securities and shall be appropriately adjusted for any stock dividends, splits, reverse splits, combinations,
recapitalizations and the like occurring after the date hereof. 
 4.2. Rule 144 and Rule 144A.
If the Company shall have filed a registration statement pursuant to the requirements of Section 12 of the Exchange Act or a registration statement pursuant to the requirements of the Securities Act in respect of the Common Stock or Common
Stock Equivalents, the Company covenants that (i) so long as it remains subject to the reporting provisions of the Exchange Act, it will timely file the reports required to be filed by it under the Securities Act or the Exchange Act (including,
but not limited to, the reports under Sections 13 and 15(d) of the Exchange Act referred to in subparagraph (c)(1)(i) of Rule 144 under the Securities Act, as such Rule may be amended (“Rule 144”)) or,
if the Company is not required to file such reports, it will, upon the request of any Holder, make publicly available other information so long as necessary to permit sales by such Holder under Rule 144, Rule 144A under the Securities Act,
as such Rule may be amended (“Rule 144A”), or any similar rules or regulations hereafter adopted by the SEC, and (ii) it will take such further action as any Holder may reasonably request, all to the extent
required from time to time to enable such Holder to sell Registrable 

  
 36 

 
Securities without registration under the Securities Act within the limitation of the exemptions provided by (A) Rule 144, (B) Rule 144A, (C) Regulation S under the Securities
Act or (D) any similar rule or regulation hereafter adopted by the SEC. Upon the request of any Holder of Registrable Securities, the Company will deliver to such Holder a written statement as to whether it has complied with such requirements.

 4.3. Nominees for Beneficial Owners. If Registrable Securities are held by a nominee for the beneficial owner thereof, the
beneficial owner thereof may, at its option, be treated as the Holder of such Registrable Securities for purposes of any request or other action by any Holder or Holders of Registrable Securities pursuant to this Agreement (or any determination of
any number or percentage of shares constituting Registrable Securities held by any Holder or Holders of Registrable Securities contemplated by this Agreement); provided, however, that the Company shall have received assurances
reasonably satisfactory to it of such beneficial ownership. 
 4.4. Amendments and Waivers. Except as otherwise provided herein, no
modification, amendment or waiver of any provision of this Agreement shall be effective against the Company or any Holder unless such modification, amendment or waiver is approved in writing by the Company and the Sponsor Investors; provided
that any modification, amendment or waiver of any of provision of this Agreement which adversely affects any Holder disproportionately as compared to the Sponsor Investors shall not be effective without the written approval of such Holder. No waiver
of any of the provisions of this Agreement shall be deemed to or shall constitute a waiver of any other provision hereof (whether or not similar). No failure or delay on the part of any party in exercising any right, power or privilege hereunder
shall operate as a waiver thereof or of any other or future exercise of any such right, power or privilege. 
 4.5. Notices. All
notices, demands and other communications to be given or delivered under or by reason of the provisions of this Agreement shall be in writing and shall be deemed to have been given (i) if personally delivered, on the date of delivery,
(ii) if delivered by express courier service of national standing (with charges prepaid), on the Business Day following the date of delivery to such courier service, (iii) if deposited in the United States mail, first-class postage prepaid, on the fifth (5th) Business Day following the date of such deposit, (iv) if delivered by facsimile transmission, upon
confirmation of successful transmission, (x) on the date of such transmission, if such transmission is completed at or prior to 5:00 p.m., local time of the recipient party on a Business Day, on the date of such transmission, and (y) on
the next Business Day following the date of transmission, if such transmission is completed after 5:00 p.m., local time of the recipient party, on the date of such transmission or is transmitted on a day that is not a Business Day, or (v) if
via e-mail communication, on the date of delivery. All notices, demands and other communications hereunder shall be delivered as set forth below and to any other recipient at the address indicated on
Schedule 4.5 hereto and to any subsequent holder of securities subject to this Agreement at such address as indicated by the Company’s records, or pursuant to such other instructions as may be designated in writing by
the party to receive such notice: 
 if to the Company, to: 

Traeger, Inc. 
 1215 E
Wilmington Ave., Suite 200 
 Salt Lake City, Utah 84106 

  
 37 

 Attention: Thomas Burton, General Counsel 

Email:       tburton@traegergrills.com 

c/o AEA Investors LP 
 520
Madison Avenue, 40th Floor 
 New York, NY 10022 

Attention: Barbara L. Burns 

Fax:          (212) 702-0518 

Email:      bburns@aeainvestors.com 

with a copy (which shall not constitute notice) to: 

Latham & Watkins LLP 

1271 Avenue of the Americas 

New York, New York 10020 

Telephone: (212) 906-1200 

Attention: Stelios G. Saffos 

                 Shayne Kennedy 

                 Ian D. Schuman 

Email:      stelios.saffos@lw.com, 

                 shayne.kennedy@lw.com 

                 ian.schuman@lw.com 

if to the AEA Investors, to: 

AEA Investors LP 
 520 Madison
Avenue, 40th Floor 
 New York, NY 10022 

Attention: Barbara L. Burns 

Fax:        (212) 702-0518 

Email:    bburns@aeainvestors.com 

with a copy (which shall not constitute notice) to: 

Fried, Frank, Harris, Shriver & Jacobson LLP 

One New York Plaza 
 New York,
New York 10004 
 Telephone: (212) 859-8000 

Fax:            (212) 859-4000 

Attention: Steven J. Steinman 

Randi Lally 
 Email:
steven.steinman @friedfrank.com 
             randi.lally@friedfrank.com 

  
 38 

 if to the Management Investors, to: 

[ 🌑 ] 

if to the OTPP Investors, to: 

c/o Ontario Teachers’ Pension Plan 

5650 Yonge Street 
 Toronto,
Ontario M2M 4H5 
 Attention: Harj Shoan 

Telephone: (416) 730-3510 

Fax:            (416) 730-3771 

Email:        harj_shoan@otpp.com 

                   law_investments@otpp.com

 with a copy (which shall not constitute notice) to: 

Torys LLP 
 79 Wellington Street
West, Suite 3000 
 Toronto, Ontario M5K 1N2 

Attention: Laurie N. Duke 

Telephone: 416-865-7348 

Fax:            
416-865-7380 
 Email: lduke@torys.com 

if to the TCP Investors, to: 

c/o Trilantic Capital Partners 

375 Park Avenue, 30th Floor 

New York, NY 10152 
 Attention:
James Manges, 
                   Grant Palmer

 Facsimile: (646) 368-6988 

E-mail:      JManges@trilantic.com, 

                 grant.palmer@trilantic.com 

with a copy (which shall not constitute notice) to: 

Kirkland & Ellis LLP 

601 Lexington Ave. 
 New York,
New York 10022 
 Telephone: (212) 446-4800 

Fax:            (212) 446-6460 

Attention:   Christopher J. Torrente 

Email:         christopher.torrente@kirkland.com 

if to the other Holders, to the address set forth opposite the name of such other Holder on Schedule 4.5 or such other address
indicated in the records of the Company. 

  
 39 

 4.6. Successors and Assigns. Except as otherwise provided herein, this Agreement
shall be binding upon and inure to the benefit of and be enforceable by the parties hereto and the respective successors, permitted assigns, heirs and personal representatives of the parties hereto, whether so expressed or not and shall also apply
to any securities acquired by a Holder after the date hereof. This Agreement may not be assigned by the Company without the prior written consent of the AEA Investors. This Agreement may not be assigned by any Holder without the consent of the
Company and, in the case of the Minority Investors, the prior written consent of the AEA Investors; provided, that: (a) any AEA Investor may assign any of its rights and obligations under this Agreement to any other AEA Investor without
the consent of the Company; and (b) any Minority Investor may assign its rights and obligations under this Agreement to any of its Permitted Affiliate Transferees without the prior written consent of the Company or the AEA Investors;
provided, further, that any assigning Holder and the applicable assignee each executes and delivers to the Company an Assumption Agreement; and provided, further, that the assigning Holder shall not be liable for any
obligations hereunder of the assignee, other than with respect to any assignee that is an Affiliate of the assigning Holder. Upon any such permitted assignment, such assignee shall have and be able to exercise and enforce all rights of the assigning
Holder which are assigned to it (to the extent set forth in the Assumption Agreement) and, to the extent such rights are assigned, any reference to the assigning Holder shall be treated as a reference to the assignee (to the extent set forth in the
Assumption Agreement). If any Holder shall acquire additional Registrable Securities, such Registrable Securities shall be subject to all of the terms, and entitled to all the benefits, of this Agreement. In addition, subject to Section 2.10,
additional Persons may become parties to this Agreement as a “Minority Investor” with the consent of the Company and the AEA Investors by executing and delivering to the Company a joinder to this Agreement in form and substance reasonably
satisfactory to the Company and the AEA Investors. 
 4.7. Entire Agreement. This Agreement, the Limited Partnership Agreement and
the other documents referred to herein or delivered pursuant hereto which form part hereof constitute the entire agreement and understanding between the parties hereto and supersede all prior agreements and understandings relating to the subject
matter hereof. 
 4.8. Governing Law; Jurisdiction; Court Proceedings; Waiver of Jury Trial. 

(a) This Agreement shall be governed by, and construed in accordance with, the internal laws of the State of New York. Each of the Parties
irrevocably submits to the exclusive jurisdiction of the Commercial Division of the New York Supreme Court located in in the Borough of Manhattan in the City of New York and the United States District Court for the Southern District of New York for
the purpose of any suit, action, proceeding or judgment relating to or arising out of this Agreement and the transactions contemplated hereby. Service of process in connection with any such suit, action or proceeding may be served on each Party
anywhere in the world by the same methods as are specified for the giving of notices under this Agreement. Each of the Parties irrevocably waives any objection to the laying of venue of any such suit, action or proceeding brought in such courts and
irrevocably waives any claim that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum. EACH OF THE PARTIES HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT TO REQUEST
A TRIAL BY JURY IN ANY LITIGATION WITH RESPECT TO THIS AGREEMENT. 

  
 40 

 4.9. Interpretation; Construction. 

(a) The table of contents and headings in this Agreement are for convenience of reference only, do not constitute part of this Agreement and
shall not be deemed to limit or otherwise affect any of the provisions hereof. Where a reference in this Agreement is made to a Section, such reference shall be to a Section of this Agreement unless otherwise indicated. Whenever the words
“include,” “includes” or “including” are used in this Agreement, they shall be deemed to be followed by the words “without limitation.” 

(b) The parties have participated jointly in negotiating and drafting this Agreement. In the event that an ambiguity or a question of intent
or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provision of this Agreement.

 4.10. Counterparts. This Agreement may be executed and delivered in any number of separate counterparts (including by facsimile or
electronic mail), each of which shall be an original, but all of which together shall constitute one and the same agreement. 
 4.11.
Severability. The provisions of this Agreement shall be deemed severable and the invalidity or unenforceability of any provision shall not affect the validity or enforceability of the other provisions hereof. If any provision of this
Agreement, or the application thereof to any person or any circumstance, is invalid or unenforceable, (a) a suitable and equitable provision shall be substituted therefor in order to carry out, so far as may be valid and enforceable, the intent
and purpose of such invalid or unenforceable provision and (b) the remainder of this Agreement and the application of such provision to other persons or circumstances shall not be affected by such invalidity or unenforceability, nor shall such
invalidity or unenforceability affect the validity or enforceability of such provision, or the application thereof, in any other jurisdiction. 

4.12. Remedies. The parties hereto agree that irreparable damage would occur in the event that any of the provisions of this Agreement
were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that each party hereto shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce
specifically the terms and provisions of this Agreement, without the posting of any bond, and, if any action should be brought in equity to enforce any of the provisions of this Agreement, none of the parties hereto shall raise the defense that
there is an adequate remedy at Law. All remedies, either under this Agreement, by Law, or otherwise afforded to any party, shall be cumulative and not alternative. 

4.13. Further Assurances. Each party hereto shall do and perform or cause to be done and performed all such further acts and things and
shall execute and deliver all such other agreements, certificates, instruments, and documents as any other party hereto reasonably may request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the
transactions contemplated hereby. 

  
 41 

 4.14. Confidentiality. Each Holder agrees that any
non-public information which such Holder may receive relating to the Company or its Subsidiaries (the “Confidential Information”) will be held strictly confidential and will not be disclosed
by it to any Person without the express written permission of the Company for the period in which it owns shares of Common Stock and for two (2) years thereafter; provided, however, that the Confidential Information may be
disclosed (i) in the event of any compulsory legal process or to comply with any applicable Law, subpoena or other legal process or in connection with any filings that the Holder may be required to make with any regulatory authority;
provided, however, that in the event of compulsory legal process, unless prohibited by applicable Law or that process, each Holder agrees (A) to give the AEA Investors and the Company prompt notice thereof and to cooperate with
the Company and the AEA Investors in securing a protective order in the event of compulsory disclosure and (B) that any disclosure made pursuant to public filings will be subject to the prior reasonable review of the Company and the AEA
Investors, (ii) to any foreign or domestic governmental or quasi-governmental regulatory authority, including without limitation, any stock exchange or other self-regulatory organization having jurisdiction over such party, (iii) (x) to
each Holder’s Affiliates or to its or its Affiliates’ officers, directors, employees, partners, limited partners, beneficiaries, accountants, lawyers and other professional advisors and current or prospective lenders (or other sources of
debt financing) and (y) current or prospective limited partners, investors or other holders of equity in any Sponsor Investor for use relating solely to management of the investment or administrative purposes with respect to such Holder or to
the extent such information is required to be provided or is customarily provided to current limited partners, investors or holders of equity of any such Holder or Affiliate thereof (collectively, “Holder Representatives”);
provided, that such Holder shall be liable for any breach of this Section 4.14 by such Holder Representative who has received Confidential Information from such Holder, (iv) to a bona fide proposed transferee of securities of the
Company held by a Holder in accordance with Section 6 of the Limited Partnership Agreement; provided, however, that such Holder informs the proposed transferee of the confidential nature of the information and the
proposed transferee agrees in writing to comply with the restrictions in this Section 4.14 and delivers a copy of such writing to the Company, (v) by any Sponsor Investor, in the course of its normal reporting activities to its investors,
and current and prospective partners, equity holders and beneficiaries with respect to the following types of Confidential Information related to the investment by such Sponsor Investor, as applicable, in shares of Common Stock: (1) the cost
and value of such OTPP Investor’s or TCP Investor’s shares of Common Stock and (2) a general description of the Company and its Subsidiaries, including their respective names and industry and information regarding their respective
businesses, financial conditions and results of operations; provided, that this clause (v) shall not be deemed to permit any Sponsor Investor to make any disclosure of Confidential Information (including the name of the Company or any of
its Subsidiaries) by way of a press release or otherwise, and (vi) to any rating agency when required by it (it being understood that prior to such disclosure, such rating agency shall undertake to preserve the confidentiality of such
Confidential Information). 
 4.15. IPO. Subject to the Limited Partnership Agreement and the Governance Agreement, to the extent
that the Board elects to effect an initial public offering of the Company or substantially all of the business of the Company (through a subsidiary or parent company of TGP Holdings LP or through any other Person formed by the Company or into which
the Company converts or merges or transfers all or substantially all of its assets), the provisions of this Agreement shall be appropriately adjusted, and the Holders and the Company shall enter into such further agreements and arrangements as shall
be reasonably necessary or appropriate to provide the Holders with substantially the same registration rights as they would have under this Agreement, giving due consideration to the nature of the entity going public, the securities being offered
and tax and other relevant considerations. 

  
 42 

 4.16. Opt-Out Requests. Each Holder
shall have the right, at any time and from time to time (including after receiving information regarding any potential public offering), to elect to not receive any notice that the Company or any other Holders otherwise are required to deliver
pursuant to this Agreement by delivering to the Company a written statement signed by such Holder that it does not want to receive any notices hereunder (an “Opt-Out Request”); in which case,
and notwithstanding anything to the contrary in this Agreement, the Company and other Holders shall not be required to, and shall not, deliver any notice or other information required to be provided to Holders hereunder to the extent that the
Company or such other Holders reasonably expect such notice or information would result in a Holder acquiring material non-public information within the meaning of Regulation FD promulgated under the
Exchange Act. An Opt-Out Request may state a date on which it expires or, if no such date is specified, shall remain in effect indefinitely. A Holder who previously has given the Company an Opt-Out Request may revoke such request at any time, and there shall be no limit on the ability of a Holder to issue and revoke subsequent Opt-Out Requests; provided,
that each Holder shall use commercially reasonable efforts to minimize the administrative burden on the Company arising in connection with any such Opt-Out Requests. 

[Remainder of Page Intentionally Left Blank] 

  
 43 

 IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the date
first above written. 
  

			
	THE COMPANY:
	
	TRAEGER, INC.
		
	By:	 	  

		 	Name:
		 	Title:

 [Signature Page to Registration Rights Agreement] 

 
			
	THE AEA INVESTORS:
	
	AEA TGP HOLDCO LP
		
	By:	 	  

		 	Name:
		 	Title:

 [Signature Page to Registration Rights Agreement] 

 
			
	MANAGEMENT INVESTORS:
	
	[                     ]
		
	By:	 	  

		 	Name:
		 	Title:

 [Signature Page to Registration Rights Agreement] 

  

 
			
	THE OTPP INVESTORS:
	
	2594868 ONTARIO LIMITED
		
	By:	 	  

		 	Name:
		 	Title:

 [Signature Page to Registration Rights Agreement] 

  

 
			
	THE TCP INVESTORS:
	
	TCP TRAEGER HOLDINGS SPV LLC
		
	By:	 	  

		 	Name:
		 	Title:

 [Signature Page to Registration Rights Agreement] 

  

 Schedule 4.5 

Notices 
  

					
	 	  	 Name
	  	 Address

	1.	  	[______]	  	[______]

  

 Exhibit A 

ASSUMPTION AGREEMENT 

This Assumption Agreement (this “Assumption Agreement”) is made as of [_____], by and among [_____] (the
“Transferring Holder”) and [_____], a Permitted Affiliate Transferee of the Transferring Holder (the “New Holder”), in accordance with that certain Registration Rights Agreement, dated as of [_______] (as amended
from time to time, the “Agreement”), by and among [______] (the “Corporation”) and the other Holders party thereto. 

WHEREAS, the Agreement requires the New Holder, as a condition to the assignment of Transferring Holders, rights under the Agreement,
to become a party to the Agreement by executing this Assumption Agreement, and upon the New Holder signing this Assumption Agreement, the Agreement will be deemed to be amended to include the New Holder as a[n] [AEA] [OTPP] [TCP] [Management]
Investor thereunder. 
 NOW, THEREFORE, in consideration of the foregoing, and of the representations, warranties, covenants and
agreements contained herein, and intending to be legally bound hereby, the parties hereto agree as follows: 
 1. Party to the
Agreement. By execution of this Assumption Agreement, as of the date hereof the New Holder is hereby made a party to the Agreement as a[n] [AEA] [OTPP] [TCP] [Management] Investor thereunder. The New Holder hereby agrees to become a party to the
Agreement and to be bound by, and subject to, all of the representations, covenants, terms and conditions of the Agreement that are applicable to, and assignable under the Agreement by, the Transferring Holder, in the same manner as if the New
Holder were an original signatory to the Agreement. Execution and delivery of this Assumption Agreement by the New Holder shall also constitute execution and delivery by the New Holder of the Agreement, without further action of any party. 

2. Defined Terms. Capitalized terms used but not defined herein shall have the meanings set forth in the Agreement unless otherwise
noted. 
 3. Representations and Warranties of the New Holder. 

a. Authorization. The New Holder has all requisite [corporate] power and authority and has taken all action necessary in order to duly
and validly approve the New Holder’s execution and delivery of, and performance of its obligations under, this Assumption Agreement. This Assumption Agreement has been duly executed and delivered by the New Holder and constitutes a legal, valid
and binding agreement of the New Holder, enforceable against the New Holder in accordance with its terms. 
 b. No Conflict. The New
Holder is not under any obligation or restriction, nor shall it assume any such obligation or restriction, that does or would materially interfere or conflict with the performance of its obligations under this Assumption Agreement. 

  
 Exhibit A 

 4. Further Assurances. The parties agree to execute and deliver any further
instruments or perform any acts which are or may become necessary to effectuate the purposes of this Assumption Agreement. 
 5.
Governing Law. This Assumption Agreement and all amendments and supplements to it, including any issues as to the meaning or validity of any part of it and the rights and obligations of the parties under it, and all actions or proceedings of
any nature whatsoever arising out of or relating to this Assumption Agreement, shall be construed in accordance with and governed by the domestic substantive Laws of the State of Delaware without giving effect to any choice of Law or conflicts of
Law provision or rule that might otherwise cause the application of the domestic substantive Laws of any other jurisdiction. 
 6.
Counterparts. This Assumption Agreement may be executed in counterparts, including by electronic transmission, each of which will be deemed an original hereof but all of which together shall constitute one and the same instrument. 

7. Entire Agreement. This Assumption Agreement, the Agreement and the other documents referred to herein or delivered pursuant hereto
which form part hereof contains the entire understanding among the parties with respect to the subject matter hereof and supersede any prior agreement between the parties hereto concerning the subject matter hereof. 

[Signature Pages Follow] 

  
 Exhibit A 

 IN WITNESS WHEREOF, intending to be legally bound hereby, the undersigned parties have executed this
Assumption Agreement as of the date first above written. 
  

	
	TRANSFERRING HOLDER
	
	[_____]
	
	By:___________________________
	Name:
	Title:
	
	NEW HOLDER
	
	[_____]
	
	By:___________________________
	Name:
	Title:
	
	Notice Address: [_____]
	[_____]
	[_____]
	Attn: [_____]
	Facsimile: [_____]

  

	
	Accepted and Agreed to as of the date first written above:
	
	COMPANY
	
	[_______]
	By: __________________________
	Name:
	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}]]